Retinoic	O
acid	O
inhibits	O
CD40	B-protein
+	O
interleukin-4	B-protein
-mediated	O
IgE	B-protein
production	O
in	O
vitro	O
.	O

To	O
elucidate	O
the	O
role	O
of	O
retinoic	O
acid	O
(	O
RA	O
)	O
in	O
anti-CD40	B-protein
+	O
interleukin-4	B-protein
(	O
IL-4	B-protein
)	O
-mediated	O
B-cell	O
activation	O
,	O
the	O
effect	O
of	O
10	O
(	O
-12	O
)	O
to	O
10	O
(	O
-6	O
)	O
mol/L	O
RA	O
was	O
studied	O
in	O
anti-CD40	B-protein
(	O
1	O
microgram/mL	O
)	O
+	O
IL-4	B-protein
(	O
5	O
ng/mL	O
)	O
-mediated	O
proliferation	O
and	O
Ig	O
synthesis	O
by	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
mononuclear	I-cell_type
cells	I-cell_type
(	O
PBMC	B-cell_type
)	O
and	O
B	B-cell_type
cells	I-cell_type
in	O
healthy	O
donors	O
.	O

Anti-CD40	B-protein
+	O
IL-4	B-protein
-mediated	O
proliferation	O
of	O
PBMC	B-cell_type
and	O
B	B-cell_type
cells	I-cell_type
was	O
inhibited	O
by	O
RA	O
in	O
a	O
dose-dependent	O
manner	O
,	O
with	O
maximal	O
inhibition	O
of	O
62	O
%	O
+/-	O
5	O
%	O
in	O
PBMC	B-cell_type
and	O
55	O
%	O
+/-	O
4.4	O
%	O
in	O
B	B-cell_type
cells	I-cell_type
by	O
all-trans	O
RA	O
,	O
and	O
58	O
%	O
+/-	O
6.7	O
%	O
and	O
51	O
%	O
+/-	O
4.7	O
%	O
,	O
respectively	O
by	O
13-cis	O
RA	O
.	O

IgE	B-protein
synthesis	O
was	O
even	O
more	O
markedly	O
inhibited	O
by	O
RA	O
starting	O
at	O
concentrations	O
of	O
>	O
10	O
(	O
-14	O
)	O
mol/L	O
for	O
B	B-cell_type
cells	I-cell_type
and	O
>	O
10	O
(	O
-10	O
)	O
mol/L	O
for	O
PBMC	B-cell_type
.	O

Maximal	O
inhibition	O
of	O
IgE	B-protein
production	O
for	O
B	B-cell_type
cells	I-cell_type
was	O
at	O
10	O
(	O
-8	O
)	O
mol/L	O
for	O
all-trans	O
RA	O
(	O
94	O
%	O
+/-	O
1.8	O
%	O
)	O
and	O
96	O
%	O
+/-	O
3.2	O
%	O
for	O
13-cis	O
RA	O
.	O

Low	O
concentrations	O
of	O
RA	O
inhibiting	O
IgE	B-protein
synthesis	O
(	O
10	O
(	O
-10	O
)	O
mol/L	O
)	O
affected	O
neither	O
B-cell	O
proliferation	O
nor	O
the	O
production	O
of	O
IgA	B-protein
,	O
IgG	B-protein
,	O
and	O
IgM	B-protein
.	O

Elucidation	O
of	O
the	O
mechanism	O
involved	O
in	O
this	O
inhibition	O
of	O
IgE	B-protein
production	O
shows	O
that	O
epsilon	O
germline	B-DNA
transcription	O
is	O
decreased	O
by	O
RA	O
,	O
whereas	O
production	O
of	O
interferon-gamma	B-protein
(	O
IFN-gamma	B-protein
)	O
was	O
not	O
enhanced	O
in	O
the	O
presence	O
of	O
RA	O
.	O

To	O
differentiate	O
whether	O
the	O
RA	O
effect	O
was	O
mediated	O
by	O
RA	B-protein
receptors	I-protein
alpha	I-protein
,	I-protein
beta	I-protein
,	I-protein
and	I-protein
gamma	I-protein
,	O
the	O
expression	O
of	O
the	O
retinoic	B-protein
acid	I-protein
receptors	I-protein
(	O
RAR	B-protein
)	O
was	O
examined	O
by	O
reverse	B-protein
transcriptase	I-protein
-polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
.	O

The	O
data	O
show	O
that	O
unstimulated	B-cell_type
human	I-cell_type
peripheral	I-cell_type
B	I-cell_type
cells	I-cell_type
express	O
mRNA	O
of	O
the	O
RA	B-protein
receptor	I-protein
alpha	I-protein
,	I-protein
beta	I-protein
,	I-protein
and	I-protein
gamma	I-protein
.	O

Using	O
retinoids	O
with	O
different	O
receptor	O
binding	O
specificity	O
(	O
CD336	O
,	O
CD437	O
,	O
CD2019	O
,	O
CD367	O
)	O
,	O
dose-dependent	O
inhibition	O
of	O
IgE	B-protein
synthesis	O
was	O
shown	O
by	O
all	O
four	O
derivates	O
,	O
but	O
was	O
most	O
marked	O
by	O
an	O
RA	O
binding	O
the	O
alpha	B-protein
receptor	I-protein
with	O
high	O
specificity	O
.	O

Taken	O
together	O
,	O
this	O
study	O
shows	O
that	O
RA	O
inhibits	O
IgE	B-protein
production	O
of	O
anti-CD40	B-cell_line
+	I-cell_line
IL-4-stimulated	I-cell_line
B	I-cell_line
cells	I-cell_line
in	O
vitro	O
.	O

Copyright	O
1998	O
by	O
The	O
American	O
Society	O
of	O
Hematology	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Retinoic	NULL
Acid	NULL
Inhibits	NULL
CD40	NULL
+	NULL
Interleukin-4-Mediated	NULL
IgE	NULL
Production	NULL
In	NULL
Vitro	NULL
By	NULL
M.	NULL
Worm	NULL
,	NULL
J.M	NULL
.	NULL

Krah	NULL
,	NULL
R.A.	NULL
Manz	NULL
,	NULL
and	NULL
B.M	NULL
.	NULL

Henz	NULL
To	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
in	NULL
anti-CD40	NULL
+	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
-mediated	NULL
B-cell	NULL
activation	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
10-2	NULL
to	NULL
10-	NULL
``	NULL
mol/L	NULL
RA	NULL
was	NULL
studied	NULL
in	NULL
anti-CD40	NULL
(	NULL
1	NULL
pg/mL	NULL
)	NULL
+	NULL
IL-4	NULL
(	NULL
5	NULL
ng/mL	NULL
)	NULL
-mediated	NULL
proliferation	NULL
and	NULL
Ig	NULL
synthesis	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
and	NULL
B	NULL
cells	NULL
in	NULL
healthy	NULL
donors	NULL
.	NULL

Anti-CD40	NULL
+	NULL
IL-4-mediated	NULL
proliferation	NULL
of	NULL
PBMC	NULL
and	NULL
B	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
RA	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
with	NULL
maximal	NULL
inhibition	NULL
of	NULL
62	NULL
%	NULL
+	NULL
5	NULL
%	NULL
in	NULL
PBMC	NULL
and	NULL
55	NULL
%	NULL
+	NULL
4.4	NULL
%	NULL
in	NULL
B	NULL
cells	NULL
by	NULL
all-frans	NULL
RA	NULL
,	NULL
and	NULL
58	NULL
%	NULL
+	NULL
6.7	NULL
%	NULL
and	NULL
51	NULL
%	NULL
+	NULL
4.7	NULL
%	NULL
,	NULL
respectively	NULL
by	NULL
13-cis	NULL
RA	NULL
.	NULL

IgE	NULL
synthesis	NULL
was	NULL
even	NULL
more	NULL
markedly	NULL
inhibited	NULL
by	NULL
RA	NULL
starting	NULL
at	NULL
concentrations	NULL
of	NULL
>	NULL
10-	NULL
!	NULL

4	NULL
mol/	NULL
L	NULL
for	NULL
B	NULL
cells	NULL
and	NULL
>	NULL
10-	NULL
!	NULL
``	NULL

mol/L	NULL
for	NULL
PBMC	NULL
.	NULL

Maximal	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
for	NULL
B	NULL
cells	NULL
was	NULL
at	NULL
10-°	NULL
mol/	NULL
L	NULL
for	NULL
all-trans	NULL
RA	NULL
(	NULL
94	NULL
%	NULL
+	NULL
1.8	NULL
%	NULL
)	NULL
and	NULL
96	NULL
%	NULL
+	NULL
3.2	NULL
%	NULL
for	NULL
13-cis	NULL
RA	NULL
.	NULL

Low	NULL
concentrations	NULL
of	NULL
RA	NULL
inhibiting	NULL
IgE	NULL
synthesis	NULL
(	NULL
10-'°	NULL
mol/L	NULL
)	NULL
affected	NULL
neither	NULL
B-cell	NULL
proliferation	NULL
nor	NULL
the	NULL
production	NULL
of	NULL
IgA	NULL
,	NULL
IgG	NULL
,	NULL
and	NULL
IgM	NULL
.	NULL

Elucidation	NULL
of	NULL
the	NULL
ETINOIDS	NULL
ARE	NULL
DERIVED	NULL
from	NULL
vitamin	NULL
A	NULL
and	NULL
are	NULL
widely	NULL
used	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
dermatologic	NULL
disorders	NULL
such	NULL
as	NULL
acne	NULL
and	NULL
psoriasis	NULL
.	NULL

!	NULL

Their	NULL
biologic	NULL
effects	NULL
include	NULL
the	NULL
regulation	NULL
of	NULL
growth	NULL
and	NULL
differentiation	NULL
in	NULL
a	NULL
number	NULL
of	NULL
cell	NULL
types	NULL
primarily	NULL
of	NULL
epithelial	NULL
bone	NULL
marrow	NULL
origin	NULL
.	NULL

Recently	NULL
,	NULL
retinol	NULL
and	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
proliferation	NULL
of	NULL
isolated	NULL
mature	NULL
and	NULL
precursor	NULL
B	NULL
cells	NULL
from	NULL
normal	NULL
donors	NULL
after	NULL
mitogenic	NULL
stimulation	NULL
.	NULL
``	NULL

The	NULL
role	NULL
of	NULL
RA	NULL
on	NULL
CD40	NULL
+	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
-mediated	NULL
IgE	NULL
synthesis	NULL
has	NULL
,	NULL
however	NULL
,	NULL
not	NULL
yet	NULL
been	NULL
studied	NULL
.	NULL

Stimulation	NULL
of	NULL
human	NULL
B	NULL
cells	NULL
by	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
results	NULL
in	NULL
proliferation	NULL
and	NULL
IgE	NULL
production	NULL
.	NULL

``	NULL
*	NULL
Class	NULL
switching	NULL
factors	NULL
such	NULL
as	NULL
IL-4	NULL
induce	NULL
expression	NULL
of	NULL
the	NULL
germline	NULL
transcript	NULL
of	NULL
the	NULL
Ce	NULL
gene	NULL
,	NULL
which	NULL
maintains	NULL
an	NULL
open	NULL
chromatin	NULL
structure	NULL
in	NULL
this	NULL
region	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
CD40	NULL
results	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
class	NULL
switching	NULL
machinery	NULL
for	NULL
S-S	NULL
recombination	NULL
.	NULL
``	NULL

Interaction	NULL
between	NULL
CD40	NULL
on	NULL
B	NULL
cells	NULL
and	NULL
CD4OL	NULL
on	NULL
T	NULL
cells	NULL
is	NULL
critical	NULL
for	NULL
T-cell-dependent	NULL
isotype	NULL
switching	NULL
,	NULL
because	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
disruption	NULL
of	NULL
the	NULL
CD4OL	NULL
gene	NULL
causes	NULL
X-chromosome-linked	NULL
immune	NULL
deficiency	NULL
,	NULL
characterized	NULL
by	NULL
decreased	NULL
serum	NULL
IgA	NULL
,	NULL
IgG	NULL
and	NULL
IgE	NULL
levels	NULL
.	NULL
``	NULL

Anti-CD40	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
)	NULL
mimic	NULL
the	NULL
effect	NULL
of	NULL
€CD4O0L	NULL
and	NULL
anti-CD40	NULL
MoAb	NULL
plus	NULL
IL-4	NULL
induce	NULL
IgE	NULL
production	NULL
in	NULL
vitro	NULL
.	NULL

CD40	NULL
+	NULL
IL-4-mediated	NULL
IgE	NULL
production	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
various	NULL
cytokines	NULL
including	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
,	NULL
IL-8	NULL
,	NULL
IL-10	NULL
,	NULL
and	NULL
IL-12	NULL
and	NULL
by	NULL
various	NULL
other	NULL
factors	NULL
such	NULL
as	NULL
hormones	NULL
.	NULL

``	NULL
>	NULL
In	NULL
search	NULL
of	NULL
molecules	NULL
that	NULL
might	NULL
induce	NULL
a	NULL
therapeutic	NULL
downregulation	NULL
of	NULL
IgE	NULL
synthesis	NULL
,	NULL
which	NULL
is	NULL
considered	NULL
to	NULL
be	NULL
a	NULL
basic	NULL
effect	NULL
in	NULL
atopic	NULL
diseases	NULL
,	NULL
we	NULL
have	NULL
chosen	NULL
here	NULL
to	NULL
study	NULL
the	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
B-cell	NULL
activation	NULL
including	NULL
IgE	NULL
production	NULL
.	NULL

The	NULL
present	NULL
data	NULL
show	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
RA	NULL
induces	NULL
a	NULL
dose-dependent	NULL
,	NULL
selective	NULL
inhibition	NULL
of	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
proliferation	NULL
and	NULL
even	NULL
more	NULL
reduction	NULL
of	NULL
IgE	NULL
production	NULL
by	NULL
human	NULL
peripheral	NULL
B	NULL
lymphocytes	NULL
,	NULL
with	NULL
the	NULL
latter	NULL
acting	NULL
at	NULL
the	NULL
level	NULL
of	NULL
epsilon	NULL
germline	NULL
transcription	NULL
most	NULL
likely	NULL
via	NULL
retinoic	NULL
acid	NULL
receptor	NULL
(	NULL
RAR	NULL
)	NULL
a	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

-	NULL
Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
buffy	NULL
coats	NULL
of	NULL
nonallergic	NULL
healthy	NULL
donors	NULL
by	NULL
ficoll	NULL
hypaque	NULL
Blood	NULL
,	NULL
Vol	NULL
92	NULL
,	NULL
No	NULL
5	NULL
(	NULL
September	NULL
1	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
1713-1720	NULL
mechanism	NULL
involved	NULL
in	NULL
this	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
shows	NULL
that	NULL
epsilon	NULL
germline	NULL
transcription	NULL
is	NULL
decreased	NULL
by	NULL
RA	NULL
,	NULL
whereas	NULL
production	NULL
of	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
was	NULL
not	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RA	NULL
.	NULL

To	NULL
differentiate	NULL
w	NULL
hether	NULL
the	NULL
RA	NULL
effect	NULL
was	NULL
mediated	NULL
by	NULL
RA	NULL
receptors	NULL
«	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
retinoic	NULL
acid	NULL
receptors	NULL
(	NULL
RAR	NULL
)	NULL
was	NULL
examined	NULL
by	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCB	NULL
)	NULL
.	NULL

The	NULL
data	NULL
show	NULL
that	NULL
unstimulated	NULL
human	NULL
peripheral	NULL
B	NULL
cells	NULL
express	NULL
mRNA	NULL
of	NULL
the	NULL
RA	NULL
receptor	NULL
«	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
.	NULL

Using	NULL
retinoids	NULL
with	NULL
different	NULL
receptor	NULL
binding	NULL
specificity	NULL
(	NULL
CD336	NULL
,	NULL
CD437	NULL
,	NULL
CD2019	NULL
,	NULL
CD367	NULL
)	NULL
,	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
IgE	NULL
synthesis	NULL
was	NULL
shown	NULL
by	NULL
all	NULL
four	NULL
derivates	NULL
,	NULL
but	NULL
was	NULL
most	NULL
marked	NULL
by	NULL
an	NULL
RA	NULL
binding	NULL
the	NULL
«	NULL
receptor	NULL
with	NULL
high	NULL
specificity	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
this	NULL
study	NULL
shows	NULL
that	NULL
RA	NULL
inhibits	NULL
IgE	NULL
production	NULL
of	NULL
anti-CD40	NULL
+	NULL
IL-4-stimulated	NULL
B	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

separation	NULL
(	NULL
1,400	NULL
rpm	NULL
,	NULL
30	NULL
minutes	NULL
,	NULL
room	NULL
temperature	NULL
)	NULL
.	NULL

B	NULL
cells	NULL
were	NULL
purified	NULL
using	NULL
anti-CD19-coupled	NULL
magnetic	NULL
beads	NULL
(	NULL
Dianova	NULL
,	NULL
Hamburg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
and	NULL
antibody-conjugated	NULL
beads	NULL
(	NULL
1:5	NULL
ratio	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
on	NULL
ice	NULL
,	NULL
then	NULL
CD19-positive	NULL
B	NULL
cells	NULL
were	NULL
selected	NULL
by	NULL
magnetic	NULL
separation	NULL
and	NULL
after	NULL
several	NULL
washings	NULL
the	NULL
cells	NULL
were	NULL
resus-pended	NULL
in	NULL
medium	NULL
and	NULL
cultured	NULL
overnight	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
next	NULL
morning	NULL
,	NULL
cells	NULL
were	NULL
separated	NULL
from	NULL
the	NULL
beads	NULL
by	NULL
several	NULL
washings	NULL
and	NULL
counted	NULL
.	NULL

The	NULL
purified	NULL
cell	NULL
population	NULL
contained	NULL
more	NULL
than	NULL
95	NULL
%	NULL
B	NULL
cells	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
immunofluorescence	NULL
with	NULL
anti-CD20	NULL
antibody	NULL
.	NULL

In	NULL
previous	NULL
studies	NULL
,	NULL
this	NULL
procedure	NULL
has	NULL
been	NULL
shown	NULL
not	NULL
to	NULL
activate	NULL
B	NULL
cells	NULL
.	NULL

!	NULL
``	NULL

CD19/IgM	NULL
double-positive	NULL
PBMC	NULL
were	NULL
sorted	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Bergisch-Gladbach	NULL
,	NULL
Germany	NULL
)	NULL
by	NULL
magnetic	NULL
cell	NULL
sorting	NULL
(	NULL
MACS	NULL
)	NULL
with	NULL
the	NULL
CD19	NULL
Multi	NULL
Sort	NULL
Kit	NULL
.	NULL

Briefly	NULL
,	NULL
PBMC	NULL
were	NULL
enriched	NULL
using	NULL
anti-CD19	NULL
magnetic	NULL
beads	NULL
in	NULL
combination	NULL
with	NULL
a	NULL
VS	NULL
separation	NULL
column	NULL
.	NULL

After	NULL
release	NULL
of	NULL
the	NULL
magnetic	NULL
label	NULL
,	NULL
CD19	NULL
positive	NULL
cells	NULL
were	NULL
sorted	NULL
according	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
IgM	NULL
(	NULL
VS	NULL
separation	NULL
column	NULL
)	NULL
.	NULL

All	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
Miltenyi	NULL
Biotec	NULL
.	NULL

For	NULL
fluorescent	NULL
staining	NULL
10°	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
90	NULL
uL	NULL
staining	NULL
buffer	NULL
(	NULL
2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
[	NULL
BSA	NULL
]	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
[	NULL
PBS	NULL
]	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
azide	NULL
)	NULL
with	NULL
10	NULL
uL	NULL
of	NULL
the	NULL
appropiate	NULL
antibody	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
minutes	NULL
on	NULL
ice	NULL
.	NULL

After	NULL
several	NULL
washings	NULL
,	NULL
cells	NULL
were	NULL
fixed	NULL
in	NULL
2	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
when	NULL
the	NULL
biotinylated	NULL
MoAb	NULL
was	NULL
used	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
another	NULL
30	NULL
minutes	NULL
with	NULL
streptavidin-conjugated	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
before	NULL
fixation	NULL
.	NULL

Cells	NULL
(	NULL
10°	NULL
cells/well	NULL
)	NULL
were	NULL
cultured	NULL
for	NULL
3	NULL
days	NULL
for	NULL
proliferation	NULL
and	NULL
10	NULL
days	NULL
for	NULL
IgE	NULL
assays	NULL
.	NULL

The	NULL
culture	NULL
medium	NULL
RPMI	NULL
1640	NULL
was	NULL
supplemented	NULL
with	NULL
L-glutamine	NULL
(	NULL
2	NULL
mmol/L	NULL
)	NULL
,	NULL
penicillin	NULL
(	NULL
100	NULL
U/mL	NULL
)	NULL
,	NULL
streptomy-	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Dermatology	NULL
,	NULL
Charité-Virchow	NULL
Klinikum	NULL
,	NULL
Humboldt	NULL
Universitit	NULL
and	NULL
Deutsches	NULL
Rheuma-Forschungszentrum	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
.	NULL

Submitted	NULL
December	NULL
3	NULL
,	NULL
1997	NULL
;	NULL
accepted	NULL
May	NULL
1	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
German	NULL
Research	NULL
Foundation	NULL
(	NULL
DFG	NULL
,	NULL
Wo	NULL
541/2-1	NULL
)	NULL
and	NULL
Hofmann	NULL
La	NULL
Roche	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
M.	NULL
Worm	NULL
,	NULL
MD	NULL
,	NULL
Charité-Virchow	NULL
Klinikum	NULL
,	NULL
Hautklinik	NULL
,	NULL
Schumannstr	NULL
.	NULL

20-21	NULL
,	NULL
10117	NULL
Berlin	NULL
,	NULL
Germany	NULL
;	NULL
e-mail	NULL
:	NULL
mworm	NULL
@	NULL
rz.charite.hu-berlin.de	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9205-0024	NULL
$	NULL
3.00/0	NULL
1713	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1714	NULL
140	NULL
5	NULL
A	NULL
3	NULL
120+	NULL
®	NULL
3	NULL
13	NULL
&	NULL
1004	NULL
<	NULL
i	NULL
-+-	NULL
so	NULL
+	NULL
o	NULL
?	NULL

8	NULL
&	NULL
60+	NULL
€	NULL
©	NULL
6	NULL
#	NULL
®t	NULL
£	NULL
&	NULL
»	NULL
al	NULL
o	NULL
|-	NULL
C2	NULL
Ha	NULL
2	NULL
Za	NULL
3	NULL
§o	NULL
f	NULL
9	NULL
9	NULL
#	NULL
t	NULL
9	NULL
fof	NULL
92	NULL
9	NULL
f	NULL
t	NULL
@	NULL
B	NULL
a	NULL
e	NULL
e	NULL
2	NULL
2	NULL
2	NULL
2	NULL
4	NULL
6	NULL
6	NULL
2°	NULL
f	NULL
2	NULL
?	NULL

2	NULL
2	NULL
2	NULL
2	NULL
2	NULL
2	NULL
2	NULL
£	NULL
&	NULL
S	NULL
+	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
+	NULL
13-cis	NULL
retinoic	NULL
acid	NULL
140	NULL
f	NULL
CPM	NULL
in	NULL
%	NULL
of	NULL
anti	NULL
CD-40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
10-10	NULL
10-9	NULL
R	NULL
10-5	NULL
R	NULL
10-6	NULL
R	NULL
10-11	NULL
R	NULL
10-12	NULL
10-11	NULL
10-10	NULL
R	NULL
10-9	NULL
10	NULL
-8	NULL
10	NULL
-7	NULL
10-5	NULL
10-12	NULL
%	NULL
m	NULL
F	NULL
E	NULL
S	NULL
E	NULL
%	NULL
C	NULL
S	NULL
+	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
+	NULL
13-cis	NULL
retinoic	NULL
acid	NULL
Fig	NULL
1	NULL
.	NULL

Inhibition	NULL
of	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
cell	NULL
proliferation	NULL
by	NULL
all-frans	NULL
and	NULL
13-cis	NULL
RA	NULL
.	NULL

Proliferation	NULL
of	NULL
PBMC	NULL
(	NULL
A	NULL
)	NULL
and	NULL
purified	NULL
peripheral	NULL
B	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
induced	NULL
by	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
(	NULL
1	NULL
ug/mL	NULL
and	NULL
5	NULL
ng/mL	NULL
)	NULL
and	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
all-trans	NULL
RA	NULL
or	NULL
13-cis	NULL
RA	NULL
(	NULL
10-	NULL
'	NULL
to	NULL
10-5	NULL
mol/L	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
10¢/	NULL
mL	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
days	NULL
,	NULL
and	NULL
thymidine	NULL
(	NULL
0.5	NULL
LCi	NULL
)	NULL
was	NULL
added	NULL
for	NULL
the	NULL
last	NULL
16	NULL
hours	NULL
of	NULL
culture	NULL
to	NULL
each	NULL
well	NULL
.	NULL

Each	NULL
experiment	NULL
was	NULL
done	NULL
in	NULL
triplicate	NULL
,	NULL
the	NULL
cpm	NULL
values	NULL
of	NULL
unstimulated	NULL
cells	NULL
were	NULL
<	NULL
500	NULL
cpm	NULL
and	NULL
ranged	NULL
after	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
from	NULL
20,000	NULL
to	NULL
30,000	NULL
cpm	NULL
for	NULL
PBMC	NULL
and	NULL
10,000	NULL
to	NULL
20,000	NULL
for	NULL
the	NULL
B	NULL
cells	NULL
.	NULL

Anti-CD40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
was	NULL
set	NULL
at	NULL
100	NULL
%	NULL
and	NULL
mean	NULL
values	NULL
of	NULL
four	NULL
experiments	NULL
+	NULL
standard	NULL
error	NULL
of	NULL
mean	NULL
(	NULL
SEM	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

cin	NULL
(	NULL
100	NULL
mg/mL	NULL
)	NULL
and	NULL
10	NULL
%	NULL
heat	NULL
inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
all	NULL
from	NULL
Biochrom	NULL
KG	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

All	NULL
cell	NULL
cultures	NULL
were	NULL
performed	NULL
at	NULL
37°C	NULL
in	NULL
humidified	NULL
air	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
atmosphere	NULL
.	NULL

Reagents	NULL
.	NULL

IL-4	NULL
was	NULL
purchased	NULL
from	NULL
Pharmingen	NULL
(	NULL
Hamburg	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
purified	NULL
anti-CD40	NULL
MoAb	NULL
(	NULL
clone	NULL
626.1	NULL
)	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
R.	NULL
Geha	NULL
(	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
RA	NULL
(	NULL
all-trans	NULL
and	NULL
13-cis	NULL
)	NULL
were	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Stock	NULL
solutions	NULL
(	NULL
10~	NULL
mol/L	NULL
)	NULL
of	NULL
retinoids	NULL
were	NULL
prepared	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
.	NULL

Receptor	NULL
specific	NULL
retinoids	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
U.	NULL
Reichert	NULL
(	NULL
CIRD	NULL
Gal-derma	NULL
,	NULL
France	NULL
)	NULL
.	NULL

The	NULL
conjugated	NULL
anti-CD19-PE	NULL
,	NULL
anti-IgM-fluorescein	NULL
WORM	NULL
ET	NULL
AL	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
,	NULL
the	NULL
conjugated	NULL
isotype	NULL
controls	NULL
,	NULL
and	NULL
streptavi-din-PE	NULL
were	NULL
from	NULL
Pharmingen	NULL
(	NULL
Hamburg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Proliferation	NULL
assay	NULL
.	NULL

-	NULL
For	NULL
proliferation	NULL
assay	NULL
,	NULL
radioactive	NULL
thymidine	NULL
(	NULL
0.5	NULL
uCi	NULL
per	NULL
well	NULL
)	NULL
was	NULL
added	NULL
during	NULL
the	NULL
last	NULL
16	NULL
hours	NULL
of	NULL
culture	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
on	NULL
filter	NULL
paper	NULL
and	NULL
thymidine	NULL
incorporation	NULL
was	NULL
measured	NULL
using	NULL
liquid	NULL
scintillation	NULL
spectroscopy	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
and	NULL
data	NULL
expressed	NULL
as	NULL
arithmetric	NULL
means	NULL
.	NULL

Ig	NULL
production	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
10	NULL
days	NULL
,	NULL
and	NULL
Igs	NULL
were	NULL
measured	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
stimulated	NULL
cells	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
.	NULL

The	NULL
MoAb	NULL
for	NULL
IgE	NULL
detection	NULL
(	NULL
clones	NULL
IgE	NULL
in	NULL
%	NULL
of	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
-	NULL
stimulation	NULL
10-6	NULL
(	NULL
8	NULL
10-7	NULL
R	NULL
10-10	NULL
10-9	NULL
10	NULL
-8	NULL
10-7	NULL
10	NULL
12	NULL
10	NULL
10	NULL
10-9	NULL
10	NULL
-8	NULL
unstimulated	NULL
+	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
+	NULL
13-cis	NULL
retinoic	NULL
acid	NULL
120	NULL
IgE	NULL
in	NULL
%	NULL
of	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
q	NULL
e	NULL
zos	NULL
a	NULL
g	NULL
o	NULL
q	NULL
#	NULL
#	NULL
y	NULL
@	NULL
for	NULL
g	NULL
9	NULL
%	NULL
o	NULL
wo	NULL
wo	NULL
moos	NULL
i	NULL
wo	NULL
wo	NULL
wo	NULL
wo	NULL
moor	NULL
:	NULL
:	NULL
:	NULL
:	NULL
tos	NULL
o	NULL
C	NULL
:	NULL
:	NULL
:	NULL
:	NULL
Too	NULL
e	NULL
e	NULL
e	NULL
o	NULL
o	NULL
c	NULL
c	NULL
e	NULL
o	NULL
o	NULL
o	NULL
o	NULL
e	NULL
coe	NULL
c	NULL
e	NULL
a	NULL
no	NULL
c	NULL
e	NULL
e	NULL
coe	NULL
unstimulated	NULL
|	NULL
R	NULL
+	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
+	NULL
13-cis	NULL
retinoic	NULL
acid	NULL
Fig	NULL
2	NULL
.	NULL

Retinoids	NULL
inhibit	NULL
the	NULL
IgE-production	NULL
of	NULL
anti-CD40	NULL
+	NULL
IL-4-stimulated	NULL
human	NULL
PBMC	NULL
(	NULL
A	NULL
)	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
from	NULL
normal	NULL
donors	NULL
.	NULL

PBMC	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
10®/	NULL
mL	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CD40	NULL
+	NULL
IL-4	NULL
(	NULL
1	NULL
ug/mL	NULL
and	NULL
5	NULL
ng/mL	NULL
)	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
all-trans	NULL
RA	NULL
(	NULL
10-	NULL
``	NULL
°	NULL
to	NULL
10-®	NULL
mol/L	NULL
for	NULL
PBMC	NULL
and	NULL
to	NULL
mol/L	NULL
for	NULL
B	NULL
cells	NULL
)	NULL
or	NULL
13-cis	NULL
RA	NULL
(	NULL
10~	NULL
'	NULL
2	NULL
to	NULL
10~°	NULL
mol/L	NULL
for	NULL
PBMC	NULL
and	NULL
10-	NULL
'	NULL
``	NULL
to	NULL
10-8	NULL
mol/L	NULL
for	NULL
B	NULL
cells	NULL
)	NULL
.	NULL

IgE	NULL
(	NULL
pg/mL	NULL
)	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
supernatants	NULL
by	NULL
ELISA	NULL
,	NULL
IgE	NULL
in	NULL
unstimulated	NULL
PBMC	NULL
and	NULL
B	NULL
cells	NULL
was	NULL
below	NULL
200	NULL
pg/mL	NULL
and	NULL
ranged	NULL
after	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
from	NULL
2,204	NULL
to	NULL
12,846	NULL
pg/mL	NULL
in	NULL
PBMC	NULL
and	NULL
from	NULL
2,250	NULL
to	NULL
2,951	NULL
pg/mL	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Values	NULL
are	NULL
expressed	NULL
as	NULL
percent	NULL
of	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
and	NULL
mean	NULL
values	NULL
of	NULL
four	NULL
experiments	NULL
+	NULL
SEM	NULL
are	NULL
shown	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RETINOIC	NULL
ACID	NULL
AND	NULL
B	NULL
CELLS	NULL
1715	NULL
O	NULL
o	NULL
H	NULL
0	NULL
r-	NULL
&	NULL
®	NULL
©	NULL
m	NULL
©	NULL
5	NULL
3	NULL
°	NULL
0	NULL
o	NULL
9	NULL
O8	NULL
[	NULL
«	NULL
]	NULL
CJ	NULL
0	NULL
od	NULL
[	NULL
=	NULL
)	NULL
o	NULL
o	NULL
(	NULL
«	NULL
]	NULL
Fig	NULL
3	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
purified	NULL
peripheral	NULL
B	NULL
cells	NULL
from	NULL
a	NULL
nonallergic	NULL
donor	NULL
.	NULL

(	NULL
A	NULL
)	NULL
10°	NULL
B	NULL
cells	NULL
stained	NULL
w	NULL
ith	NULL
anti-CD19-PE	NULL
{	NULL
light	NULL
black	NULL
line	NULL
)	NULL
and	NULL
its	NULL
isotype	NULL
control-PE	NULL
(	NULL
bold	NULL
black	NULL
line	NULL
)	NULL
after	NULL
anti-CD19	NULL
separation	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
purified	NULL
CD19+	NULL
cells	NULL
was	NULL
96.5	NULL
%	NULL
.	NULL

(	NULL
B	NULL
)	NULL
CD19+	NULL
cells	NULL
after	NULL
IgM-FITC	NULL
30	NULL
ppp	NULL
up	NULL
fsa	NULL
40	NULL
ila	NULL
s	NULL
30	NULL
1	NULL
20	NULL
|	NULL
Jr	NULL
'	NULL
ﬂ	NULL
\	NULL
I	NULL
m	NULL
-	NULL
\	NULL
1	NULL
aa'||	NULL
``	NULL
||	NULL
``	NULL
Counts	NULL
20	NULL
go	NULL
uc	NULL
n	NULL
f	NULL
nee	NULL
4	NULL
Counts	NULL
10	NULL
anti-lIgM-selection	NULL
staining	NULL
with	NULL
fluorescein	NULL
conjugated	NULL
anti-igM	NULL
{	NULL
light	NULL
black	NULL
line	NULL
)	NULL
and	NULL
its	NULL
fluores-cein-conjugated	NULL
isotype	NULL
control	NULL
L	NULL
(	NULL
bold	NULL
black	NULL
line	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
purified	NULL
IgM+	NULL
cells	NULL
was	NULL
86	NULL
%	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Shows	NULL
staining	NULL
of	NULL
CD19	NULL
IgM	NULL
selected	NULL
B	NULL
cells	NULL
with	NULL
a	NULL
biotiny	NULL
!	NULL

l-	NULL
|I	NULL
ated	NULL
anti-IgE	NULL
(	NULL
2	NULL
pg/mL	NULL
,	NULL
HP6029	NULL
)	NULL
|	NULL
and	NULL
its	NULL
appropiate	NULL
biotinylated	NULL
1	NULL
isotype	NULL
control	NULL
in	NULL
the	NULL
same	NULL
con-|	NULL
centration	NULL
by	NULL
using	NULL
streptavidin-	NULL
conjugated	NULL
PE	NULL
as	NULL
a	NULL
secondary	NULL
Cuil	NULL
ior	NULL
reagent	NULL
.	NULL

IgE*	NULL
cells	NULL
were	NULL
not	NULL
de	NULL
I	NULL
A	NULL
rlll'lnl	NULL
'	NULL
u	NULL
'	NULL
y	NULL
fw	NULL
£	NULL
hen	NULL
roomate	NULL
r-mrmmyo	NULL
--	NULL
mmmmy	NULL
Ov	NULL
-t	NULL
aid	NULL
~	NULL
``	NULL
v	NULL
rm	NULL
10°	NULL
ao	NULL
``	NULL
10	NULL
``	NULL
_	NULL
10°	NULL
10	NULL
°	NULL
4	NULL
-ISA-PE	NULL
orr	NULL
ry	NULL
Table	NULL
1	NULL
.	NULL

Effects	NULL
of	NULL
all-trans	NULL
and	NULL
13-cis	NULL
Retinoic	NULL
Acid	NULL
on	NULL
IgA	NULL
,	NULL
IgG	NULL
,	NULL
and	NULL
IgE	NULL
Production	NULL
in	NULL
Anti-CD40	NULL
+	NULL
IL-4-Stimulated	NULL
IgM	NULL
+	NULL
Peripheral	NULL
B	NULL
Cells	NULL
IgA	NULL
IgG	NULL
IgE	NULL
{	NULL
ng/mL	NULL
)	NULL
{	NULL
ng/mL	NULL
)	NULL
(	NULL
pg/mL	NULL
)	NULL
Medium	NULL
<	NULL
100	NULL
<	NULL
100	NULL
<	NULL
100	NULL
Anti-CD40	NULL
+	NULL
IL-4	NULL
398	NULL
+	NULL
22	NULL
510	NULL
+	NULL
34	NULL
2040	NULL
+	NULL
126	NULL
Anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
R1	NULL
!	NULL

%	NULL
**mol/	NULL
401	NULL
+	NULL
43	NULL
480	NULL
+45	NULL
1884	NULL
+	NULL
110	NULL
Anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
R1	NULL
!	NULL

*	NULL
!	NULL

2moI/	NULL
406	NULL
+	NULL
35	NULL
490	NULL
+	NULL
38	NULL
992	NULL
+	NULL
150	NULL
Anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
mol/L	NULL
402	NULL
+	NULL
37	NULL
508	NULL
+	NULL
47	NULL
-	NULL
798	NULL
+	NULL
123	NULL
Anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
R1	NULL
!	NULL

%	NULL
®	NULL
mol/L	NULL
402	NULL
+	NULL
47	NULL
510	NULL
+42	NULL
289	NULL
+	NULL
105	NULL
Anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
R2	NULL
!	NULL

%	NULL
*+moI/l	NULL
400	NULL
+	NULL
46	NULL
496	NULL
+	NULL
38	NULL
1773	NULL
+	NULL
136	NULL
Anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
R2	NULL
!	NULL

%	NULL
*2	NULL
mol/L	NULL
409	NULL
+	NULL
37	NULL
489	NULL
+45	NULL
1649	NULL
+	NULL
156	NULL
Anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
mol/L	NULL
406	NULL
+	NULL
43	NULL
498	NULL
+	NULL
38	NULL
737	NULL
+	NULL
134	NULL
Anti-CD40	NULL
+	NULL
IL-4	NULL
+	NULL
R2	NULL
!	NULL

%	NULL
®	NULL
mol/L	NULL
-	NULL
403	NULL
+	NULL
27	NULL
491	NULL
+	NULL
42	NULL
261	NULL
+	NULL
128	NULL
Ig	NULL
M+	NULL
B	NULL
cells	NULL
(	NULL
10	NULL
%	NULL
/mL	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CD40	NULL
+	NULL
IL-4	NULL
(	NULL
1	NULL
pg/mL	NULL
and	NULL
5	NULL
ng/mL	NULL
)	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
all-trans	NULL
RA	NULL
(	NULL
R1	NULL
)	NULL
or	NULL
13-cis	NULL
RA	NULL
(	NULL
R2	NULL
)	NULL
.	NULL

Igs	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
supernatants	NULL
by	NULL
ELISA	NULL
,	NULL
values	NULL
are	NULL
shown	NULL
as	NULL
means	NULL
of	NULL
triplicates	NULL
.	NULL

Shown	NULL
is	NULL
one	NULL
representative	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

r-rmmny	NULL
IgE-bio/SA-PE	NULL
v6	NULL
r	NULL
Pry	NULL
10	NULL
tectable	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
cells	NULL
from	NULL
an	NULL
allergic	NULL
donor	NULL
were	NULL
stained	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

10	NULL
10	NULL
HP	NULL
6061	NULL
and	NULL
HP	NULL
6029	NULL
)	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Bob	NULL
Hamilton	NULL
(	NULL
Asthma	NULL
and	NULL
Allergy	NULL
Center	NULL
,	NULL
Johns	NULL
Hopkins	NULL
University	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
antibodies	NULL
for	NULL
IgA	NULL
,	NULL
IgG	NULL
,	NULL
and	NULL
IgM	NULL
ELISA	NULL
(	NULL
anti-IgA	NULL
,	NULL
anti-IgG	NULL
,	NULL
and	NULL
anti-IgM	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Dianova	NULL
(	NULL
Hamburg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
for	NULL
the	NULL
Ig	NULL
assays	NULL
,	NULL
immunoplates	NULL
(	NULL
Nunc	NULL
,	NULL
Wiesbaden	NULL
,	NULL
Germany	NULL
)	NULL
were	NULL
coated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
anti-human	NULL
Ig-Fc	NULL
antibodies	NULL
diluted	NULL
in	NULL
0.1	NULL
mol/L	NULL
bicarbonate	NULL
buffer	NULL
.	NULL

The	NULL
wells	NULL
were	NULL
then	NULL
blocked	NULL
for	NULL
1	NULL
hour	NULL
with	NULL
2	NULL
%	NULL
BSA-Tris	NULL
buffer	NULL
.	NULL

After	NULL
several	NULL
washings	NULL
,	NULL
supernatants	NULL
and	NULL
internal	NULL
standards	NULL
were	NULL
incubated	NULL
in	NULL
duplicates	NULL
overnight	NULL
.	NULL

The	NULL
next	NULL
morning	NULL
,	NULL
after	NULL
several	NULL
washes	NULL
,	NULL
the	NULL
second	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
AP	NULL
)	NULL
-conjugated	NULL
anti-Ig	NULL
(	NULL
A	NULL
;	NULL
G	NULL
;	NULL
M	NULL
)	NULL
antibody	NULL
was	NULL
added	NULL
.	NULL

Because	NULL
the	NULL
second	NULL
anti-IgE	NULL
MoAb	NULL
was	NULL
biotinylated	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
another	NULL
hour	NULL
with	NULL
alkaline	NULL
phosphatase-conjugated	NULL
streptavidin	NULL
.	NULL

After	NULL
the	NULL
final	NULL
reaction	NULL
with	NULL
phosphatase	NULL
substrate	NULL
(	NULL
Sigma	NULL
,	NULL
Dreieich	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
plates	NULL
were	NULL
read	NULL
in	NULL
a	NULL
microplate	NULL
ELISA	NULL
reader	NULL
at	NULL
410	NULL
nm	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
Ig	NULL
was	NULL
calculated	NULL
according	NULL
to	NULL
the	NULL
standard	NULL
curve	NULL
.	NULL

The	NULL
variations	NULL
of	NULL
readings	NULL
in	NULL
duplicate	NULL
cultures	NULL
never	NULL
exceeded	NULL
15	NULL
%	NULL
.	NULL

Polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
.	NULL

-	NULL
Semiquantitative	NULL
reverse	NULL
trans-criptase	NULL
(	NULL
RT	NULL
)	NULL
-PCR	NULL
was	NULL
used	NULL
for	NULL
detection	NULL
of	NULL
RAR-a-B-y	NULL
)	NULL
and	NULL
epsilon	NULL
germline	NULL
transcription	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
purified	NULL
B	NULL
cells	NULL
with	NULL
an	NULL
RNA	NULL
preparation	NULL
kit	NULL
(	NULL
Quiagen	NULL
,	NULL
Hilden	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
mRNA	NULL
was	NULL
quantified	NULL
and	NULL
reverse-transcribed	NULL
into	NULL
cDNA	NULL
by	NULL
RT	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

PCR	NULL
amplification	NULL
was	NULL
performed	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1716	NULL
%	NULL
of	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
8	NULL
WORM	NULL
ET	NULL
AL	NULL
10-15	NULL
10	NULL
44	NULL
10-13	NULL
10	NULL
412	NULL
10-41	NULL
10	NULL
10	NULL
10-9	NULL
10-8	NULL
10	NULL
15	NULL
10-14	NULL
unstimulated	NULL
ant-€D40	NULL
+	NULL
IL-4	NULL
10-13	NULL
+	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
with	NULL
RAR-specific	NULL
``	NULL
and	NULL
epsilon	NULL
germline	NULL
specific	NULL
primers	NULL
.	NULL
``	NULL

Primers	NULL
used	NULL
for	NULL
detection	NULL
of	NULL
RAR	NULL
a	NULL
were	NULL
tgg	NULL
gig	NULL
gac	NULL
tet	NULL
cee	NULL
ege	NULL
ca	NULL
for	NULL
sense	NULL
and	NULL
cee	NULL
ace	NULL
tec	NULL
gge	NULL
gic	NULL
age	NULL
gig	NULL
for	NULL
antisense	NULL
resulting	NULL
in	NULL
a	NULL
438-bp	NULL
fragment	NULL
,	NULL
for	NULL
RAR	NULL
beta	NULL
5	NULL
'	NULL
cac	NULL
tgg	NULL
ctt	NULL
gac	NULL
cat	NULL
egc	NULL
aga	NULL
cc	NULL
and	NULL
3	NULL
'	NULL
gag	NULL
agg	NULL
tgg	NULL
cat	NULL
tga	NULL
toc	NULL
agg	NULL
resulting	NULL
in	NULL
an	NULL
435-bp	NULL
fragment	NULL
and	NULL
for	NULL
RAR	NULL
gamma	NULL
sense	NULL
ggo	NULL
ctg	NULL
gge	NULL
cag	NULL
ect	NULL
gac	NULL
ctc	NULL
and	NULL
antisense	NULL
cag	NULL
ccc	NULL
cag	NULL
atc	NULL
cag	NULL
ctg	NULL
cac	NULL
g	NULL
resulting	NULL
in	NULL
a	NULL
515-bp	NULL
fragment	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
following	NULL
program	NULL
:	NULL
30	NULL
cycles	NULL
(	NULL
1	NULL
minute	NULL
at	NULL
each	NULL
94°C	NULL
,	NULL
65°C	NULL
,	NULL
and	NULL
74°C	NULL
)	NULL
.	NULL

Epsilon	NULL
germline	NULL
specific	NULL
primers	NULL
were	NULL
sense	NULL
(	NULL
GACGGGCCACAC-CAT	NULL
CCACAGGCACCAAATGGACGAC	NULL
)	NULL
of	NULL
the	NULL
I	NULL
epsilon	NULL
exon	NULL
and	NULL
antisense	NULL
(	NULL
CAGGACGACTGTAAGATCTTCACG	NULL
)	NULL
of	NULL
the	NULL
Ce	NULL
2	NULL
exon	NULL
resulting	NULL
in	NULL
a	NULL
409-bp	NULL
band	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
a	NULL
250-bp	NULL
band	NULL
corresponding	NULL
to	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
transcripts	NULL
was	NULL
amplified	NULL
using	NULL
GATGACATCAAGAAGGTGGTG	NULL
for	NULL
sense	NULL
and	NULL
GCT-GTAGCCAAATTCGTTGTC	NULL
for	NULL
antisense	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Perkin	NULL
Elmer	NULL
(	NULL
Branchburg	NULL
,	NULL
NJ	NULL
)	NULL
thermocycler	NULL
using	NULL
the	NULL
following	NULL
program	NULL
:	NULL
35	NULL
cycles	NULL
(	NULL
1	NULL
minute	NULL
at	NULL
each	NULL
94°C	NULL
,	NULL
65°C	NULL
,	NULL
and	NULL
74°C	NULL
)	NULL
for	NULL
epsilon	NULL
germline	NULL
transcripts	NULL
and	NULL
for	NULL
25	NULL
cycles	NULL
(	NULL
1	NULL
minute	NULL
each	NULL
at	NULL
94°C	NULL
,	NULL
57°C	NULL
,	NULL
and	NULL
74°C	NULL
)	NULL
for	NULL
the	NULL
GAPDH	NULL
control	NULL
.	NULL

s-germline	NULL
GAPDH	NULL
control	NULL
ant-CD4D	NULL
+	NULL
IL-4	NULL
1	NULL
pg/ml	NULL
+	NULL
5	NULL
ng/ml	NULL
+	NULL
all-trans	NULL
relnoie	NULL
actd	NULL
10°19	NULL
``	NULL
10	NULL
``	NULL
molt	NULL
Fig	NULL
5	NULL
.	NULL

-	NULL
Retinoic	NULL
acid	NULL
downregulates	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
epsilon	NULL
germline	NULL
transcription	NULL
.	NULL

Human	NULL
peripheral	NULL
B	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
(	NULL
1	NULL
ug/mL	NULL
and	NULL
5	NULL
ng/mL	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
all-frans	NULL
RA	NULL
(	NULL
10-4	NULL
,	NULL
10-12	NULL
,	NULL
10-	NULL
!	NULL

°	NULL
mol/L	NULL
)	NULL
.	NULL

Thereafter	NULL
,	NULL
mRNA	NULL
was	NULL
extracted	NULL
.	NULL

Ce	NULL
germline	NULL
and	NULL
GAPDH	NULL
transcripts	NULL
were	NULL
assessed	NULL
by	NULL
semiquantitative	NULL
RT-PCR	NULL
.	NULL

+	NULL
13-cis	NULL
retinole	NULL
acid	NULL
-	NULL
«	NULL
-IgE	NULL
-o-	NULL
IgM	NULL
-*-	NULL
IgA	NULL
-s-1gG	NULL
Fig	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
all-trans	NULL
and	NULL
13-cisretinoic	NULL
acid	NULL
on	NULL
Ig	NULL
production	NULL
by	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
2	NULL
.	NULL

Igs	NULL
(	NULL
IgA	NULL
,	NULL
IgG	NULL
,	NULL
and	NULL
a	NULL
n	NULL
g	NULL
g	NULL
og	NULL
IgM	NULL
)	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
super-eo	NULL
&	NULL
og	NULL
°	NULL
®	NULL
natants	NULL
by	NULL
ELISA	NULL
using	NULL
the	NULL
appropriate	NULL
MoAb	NULL
.	NULL

Values	NULL
are	NULL
shown	NULL
as	NULL
means	NULL
percent	NULL
of	NULL
CD40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
.	NULL

RESULTS	NULL
RA	NULL
inhibits	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
cell	NULL
proliferation	NULL
.	NULL

To	NULL
study	NULL
the	NULL
role	NULL
of	NULL
RA	NULL
in	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
cell	NULL
activation	NULL
,	NULL
we	NULL
used	NULL
different	NULL
concentrations	NULL
of	NULL
all-trans	NULL
RA	NULL
and	NULL
its	NULL
13-cis	NULL
isomer	NULL
(	NULL
10-	NULL
'	NULL
to	NULL
10-°	NULL
mol/L	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
.	NULL

A	NULL
dose-dependent	NULL
inhibition	NULL
with	NULL
both	NULL
RA	NULL
derivates	NULL
of	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
PBMC	NULL
proliferation	NULL
was	NULL
observed	NULL
.	NULL

For	NULL
quantification	NULL
of	NULL
the	NULL
antiproliferative	NULL
effect	NULL
on	NULL
CD40	NULL
+	NULL
IL-4-stimulated	NULL
cells	NULL
,	NULL
mean	NULL
values	NULL
of	NULL
stimulated	NULL
cells	NULL
were	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

A	NULL
62	NULL
%	NULL
+	NULL
5.2	NULL
%	NULL
maximal	NULL
inhibition	NULL
of	NULL
PBMC	NULL
proliferation	NULL
was	NULL
observed	NULL
at	NULL
10~-	NULL
``	NULL
mol/L	NULL
by	NULL
all	NULL
trans	NULL
retinoic	NULL
acid	NULL
and	NULL
a	NULL
58	NULL
%	NULL
+	NULL
6.3	NULL
%	NULL
maximal	NULL
inhibition	NULL
by	NULL
10	NULL
mol/L	NULL
13-cis	NULL
retinoic	NULL
acid	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
inhibition	NULL
of	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
cell	NULL
proliferation	NULL
might	NULL
be	NULL
mediated	NULL
either	NULL
through	NULL
direct	NULL
effects	NULL
on	NULL
B	NULL
cells	NULL
or	NULL
through	NULL
indirect	NULL
effects	NULL
,	NULL
eg	NULL
,	NULL
via	NULL
increased	NULL
cytokine	NULL
production	NULL
by	NULL
cells	NULL
other	NULL
than	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
next	NULL
the	NULL
effects	NULL
of	NULL
all-trans	NULL
and	NULL
13-cis	NULL
RA	NULL
on	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
B-cell	NULL
proliferation	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
inhibition	NULL
with	NULL
B	NULL
cells	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
PBMC	NULL
,	NULL
with	NULL
a	NULL
55	NULL
%	NULL
*	NULL
4.4	NULL
%	NULL
maximal	NULL
inhibition	NULL
of	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
B-cell	NULL
proliferation	NULL
for	NULL
all-trans	NULL
RA	NULL
and	NULL
51	NULL
+	NULL
4.7	NULL
for	NULL
13-cis	NULL
RA	NULL
,	NULL
both	NULL
at	NULL
10-8	NULL
Table	NULL
2	NULL
.	NULL

IFN-y	NULL
Production	NULL
by	NULL
Human	NULL
PBMC	NULL
and	NULL
B	NULL
Cells	NULL
After	NULL
48	NULL
Hours	NULL
Stimulation	NULL
in	NULL
the	NULL
Presence	NULL
of	NULL
Retinoids	NULL
Experi-	NULL
-	NULL
Experi-	NULL
Experi-	NULL
Experi-	NULL
Experi-	NULL
Experiment	NULL
1	NULL
-	NULL
ment2	NULL
-	NULL
ment3	NULL
-	NULL
ment4	NULL
-	NULL
ment5	NULL
-	NULL
ment6	NULL
Control	NULL
145	NULL
64	NULL
10	NULL
3.2	NULL
4	NULL
7	NULL
CD40	NULL
+	NULL
IL-4	NULL
123	NULL
61	NULL
5.6	NULL
3.3	NULL
<	NULL
3	NULL
<	NULL
3	NULL
CD40	NULL
+	NULL
IL-4	NULL
+	NULL
all-frans	NULL
RA	NULL
_	NULL
117	NULL
44	NULL
5.6	NULL
4.0	NULL
<	NULL
3	NULL
<	NULL
3	NULL
CD40	NULL
+	NULL
IL-4	NULL
+	NULL
13-cis	NULL
RA	NULL
35	NULL
20	NULL
5.2	NULL
5.3	NULL
<	NULL
3	NULL
<	NULL
3	NULL
Production	NULL
of	NULL
secreted	NULL
INF-y	NULL
protein	NULL
(	NULL
pg/mL	NULL
)	NULL
in	NULL
CD40	NULL
+	NULL
IL-4	NULL
activated	NULL
PBMC	NULL
(	NULL
exps	NULL
1-4	NULL
)	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
exps	NULL
5-6	NULL
)	NULL
from	NULL
normal	NULL
donors	NULL
.	NULL

IFNy	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
10¢/mL	NULL
cells	NULL
by	NULL
ELISA	NULL
after	NULL
48	NULL
hours	NULL
stimulation	NULL
with	NULL
anti-CD40	NULL
(	NULL
1	NULL
ug/mL	NULL
)	NULL
and	NULL
IL-4	NULL
(	NULL
5	NULL
ng/mL	NULL
)	NULL
and/or	NULL
all-frans	NULL
or	NULL
13-cis	NULL
RA	NULL
(	NULL
10~	NULL
``	NULL
°	NULL
mol/L	NULL
)	NULL
.	NULL

Values	NULL
are	NULL
show	NULL
n	NULL
as	NULL
means	NULL
of	NULL
duplicates	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RETINOIC	NULL
ACID	NULL
AND	NULL
B	NULL
CELLS	NULL
GAPDH	NULL
RARa	NULL
RARS	NULL
RARy	NULL
Fig	NULL
6	NULL
.	NULL

Expression	NULL
of	NULL
RAR	NULL
in	NULL
peripheral	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Human	NULL
peripheral	NULL
B	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
mRNA	NULL
was	NULL
extracted	NULL
.	NULL

RAR-specific	NULL
(	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
)	NULL
and	NULL
GADPH	NULL
transcripts	NULL
were	NULL
assessed	NULL
by	NULL
semiquantitative	NULL
RT-PCR	NULL
.	NULL

The	NULL
DNA	NULL
ladder	NULL
is	NULL
show	NULL
n	NULL
in	NULL
the	NULL
left	NULL
lane	NULL
.	NULL

mol/L	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
RA	NULL
alone	NULL
caused	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
no	NULL
proliferative	NULL
effects	NULL
on	NULL
PBMC	NULL
or	NULL
B	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

RA	NULL
inhibits	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
IgE	NULL
.	NULL

,	NULL
production	NULL
.	NULL

Because	NULL
stimulation	NULL
of	NULL
B	NULL
cells	NULL
with	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
results	NULL
not	NULL
only	NULL
in	NULL
proliferation	NULL
,	NULL
but	NULL
also	NULL
in	NULL
IgE	NULL
production	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
IgE-synthesis	NULL
.	NULL

Figure	NULL
2	NULL
shows	NULL
that	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
all-trans	NULL
and	NULL
13-cis	NULL
RA	NULL
,	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
IgE	NULL
production	NULL
was	NULL
inhibited	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
in	NULL
both	NULL
PBMC	NULL
and	NULL
CD19+	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
PBMC	NULL
,	NULL
maximal	NULL
inhibition	NULL
of	NULL
IgE	NULL
was	NULL
81	NULL
%	NULL
+	NULL
8	NULL
%	NULL
for	NULL
all-trans	NULL
RA	NULL
and	NULL
82	NULL
%	NULL
+	NULL
11.4	NULL
%	NULL
for	NULL
13-cis	NULL
RA	NULL
,	NULL
both	NULL
at	NULL
10	NULL
mol/L	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
,	NULL
and	NULL
with	NULL
B	NULL
cells	NULL
,	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
even	NULL
reached	NULL
control	NULL
levels	NULL
of	NULL
94	NULL
%	NULL
+	NULL
1.8	NULL
%	NULL
and	NULL
96	NULL
%	NULL
+	NULL
3.2	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
at	NULL
10-8	NULL
mol/L	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
in	NULL
the	NULL
B	NULL
cells	NULL
was	NULL
observed	NULL
already	NULL
at	NULL
very	NULL
low	NULL
concentrations	NULL
of	NULL
RA	NULL
(	NULL
10-4	NULL
mol/L	NULL
)	NULL
,	NULL
indicating	NULL
a	NULL
specific	NULL
effect	NULL
on	NULL
IgE	NULL
production	NULL
rather	NULL
than	NULL
on	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
.	NULL

To	NULL
provide	NULL
further	NULL
evidence	NULL
that	NULL
RA	NULL
is	NULL
not	NULL
just	NULL
affecting	NULL
the	NULL
synthesis	NULL
of	NULL
IgE	NULL
from	NULL
previously	NULL
switched	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
double	NULL
separated	NULL
CD19-IgM*	NULL
cells	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

The	NULL
data	NULL
show	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
that	NULL
inhibition	NULL
of	NULL
IgE	NULL
synthesis	NULL
after	NULL
anti-€CD40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
by	NULL
all-trans	NULL
and	NULL
13-cis	NULL
RA	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
double-purified	NULL
CD19-IgM*	NULL
B	NULL
cells	NULL
.	NULL

RA	NULL
does	NULL
not	NULL
affect	NULL
IgA	NULL
and	NULL
IgG	NULL
production	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
was	NULL
accompanied	NULL
by	NULL
inhibition	NULL
of	NULL
the	NULL
production	NULL
of	NULL
other	NULL
Igs	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
production	NULL
of	NULL
IgA	NULL
,	NULL
IgG	NULL
,	NULL
and	NULL
IgM	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
CD40	NULL
+	NULL
IL-4-stimulated	NULL
CD19*	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4	NULL
,	NULL
all-trans	NULL
and	NULL
13-cis	NULL
RA	NULL
had	NULL
hardly	NULL
any	NULL
effect	NULL
on	NULL
IgA	NULL
or	NULL
IgG	NULL
production	NULL
.	NULL

RA	NULL
concentrations	NULL
with	NULL
greater	NULL
than	NULL
50	NULL
%	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
failed	NULL
to	NULL
affect	NULL
IgA	NULL
or	NULL
IgG	NULL
production	NULL
indicating	NULL
a	NULL
more	NULL
Table	NULL
3	NULL
.	NULL

Receptor	NULL
Specificity	NULL
,	NULL
Transcriptional	NULL
Activation	NULL
Activity	NULL
After	NULL
Binding	NULL
a	NULL
Particular	NULL
Receptor	NULL
,	NULL
and	NULL
Molecular	NULL
Weights	NULL
of	NULL
the	NULL
Retinoids	NULL
Used	NULL
Receptor	NULL
Selectivity	NULL
Transcriptional	NULL
Activation	NULL
KD	NULL
(	NULL
nmol/L	NULL
)	NULL
AC50	NULL
(	NULL
nmol/L	NULL
)	NULL
RARe	NULL
-	NULL
BARB	NULL
-	NULL
RARy	NULL
-	NULL
RARe	NULL
_	NULL
RARB	NULL
__	NULL
RARy	NULL
_	NULL
(	NULL
gl	NULL
)	NULL
Retinoid	NULL
CD367	NULL
5.3	NULL
2.5	NULL
1.3	NULL
0.23	NULL
0.37	NULL
0.25	NULL
300	NULL
CD336	NULL
8.0	NULL
131	NULL
450	NULL
0.36	NULL
24.5	NULL
27.8	NULL
357	NULL
CD2019	NULL
1100	NULL
26	NULL
160	NULL
19.8	NULL
3.8	NULL
46.9	NULL
375	NULL
CD437	NULL
6500	NULL
2480	NULL
77	NULL
140	NULL
28.4	NULL
7.3	NULL
398	NULL
Abbreviation	NULL
:	NULL
MW	NULL
,	NULL
molecular	NULL
weights	NULL
.	NULL

Data	NULL
from	NULL
Bernard	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
1717	NULL
Table	NULL
4	NULL
.	NULL

Inhibition	NULL
of	NULL
IgE	NULL
Production	NULL
by	NULL
RAR-Specific	NULL
Retinoids	NULL
in	NULL
Anti-CD40	NULL
+	NULL
IL-4-Stimulated	NULL
Human	NULL
Peripheral	NULL
B	NULL
Cells	NULL
IgE	NULL
in	NULL
pg/mL	NULL
Medium	NULL
<	NULL
200	NULL
Anti-CD40	NULL
+	NULL
IL-4	NULL
2951	NULL
+	NULL
21	NULL
+CD336	NULL
972	NULL
+	NULL
18	NULL
+CD2019	NULL
2321	NULL
+	NULL
32	NULL
+CD437	NULL
2291	NULL
+	NULL
28	NULL
+CD367	NULL
632	NULL
+	NULL
12	NULL
Peripheral	NULL
B	NULL
cells	NULL
(	NULL
10¢/mL	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CD40	NULL
+	NULL
IL-4	NULL
(	NULL
1	NULL
ug/mL	NULL
and	NULL
5	NULL
ng/mL	NULL
)	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
different	NULL
RAR	NULL
specific	NULL
retinoids	NULL
(	NULL
10~	NULL
'	NULL
!	NULL
'	NULL

mol/L	NULL
)	NULL
.	NULL

IgE	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
supernatants	NULL
by	NULL
ELISA	NULL
and	NULL
values	NULL
are	NULL
shown	NULL
as	NULL
means	NULL
of	NULL
triplicates	NULL
.	NULL

Shown	NULL
is	NULL
one	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

selective	NULL
effect	NULL
of	NULL
RA	NULL
on	NULL
IgE	NULL
production	NULL
.	NULL

This	NULL
finding	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
using	NULL
CD19-IgM+*	NULL
B	NULL
cells	NULL
in	NULL
which	NULL
induction	NULL
of	NULL
IgA	NULL
and	NULL
IgG	NULL
production	NULL
after	NULL
stimulation	NULL
with	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
was	NULL
detected	NULL
and	NULL
,	NULL
which	NULL
was	NULL
not	NULL
inhibitd	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
all-trans	NULL
or	NULL
13-cis	NULL
RA	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Because	NULL
stimulation	NULL
of	NULL
B	NULL
cells	NULL
with	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
results	NULL
not	NULL
only	NULL
in	NULL
IgE	NULL
,	NULL
but	NULL
also	NULL
IgM	NULL
production	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
all-trans	NULL
and	NULL
13-cis	NULL
RA	NULL
on	NULL
anti-CD40	NULL
+	NULL
IL-4-induced	NULL
IgM	NULL
production	NULL
.	NULL

All-frans	NULL
RA	NULL
caused	NULL
a	NULL
modest	NULL
inhibition	NULL
of	NULL
IgM	NULL
production	NULL
in	NULL
CD40	NULL
+	NULL
IL-4-stimulated	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
13-cis	NULL
RA	NULL
resulted	NULL
in	NULL
a	NULL
more	NULL
marked	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
IgM	NULL
production	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
,	NULL
but	NULL
only	NULL
at	NULL
higher	NULL
RA	NULL
concentrations	NULL
(	NULL
10~°	NULL
and	NULL
10-8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
maximal	NULL
inhibition	NULL
of	NULL
IgM	NULL
production	NULL
was	NULL
significantly	NULL
lower	NULL
compared	NULL
with	NULL
the	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
.	NULL

RA	NULL
inhibits	NULL
epsilon	NULL
germline	NULL
transcription	NULL
.	NULL

Production	NULL
of	NULL
epsilon	NULL
germline	NULL
transcription	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
the	NULL
isotype	NULL
switching	NULL
to	NULL
IgE	NULL
.	NULL
``	NULL

To	NULL
examine	NULL
whether	NULL
RA-mediated	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
occurs	NULL
directly	NULL
at	NULL
this	NULL
level	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
expression	NULL
of	NULL
germline	NULL
Ce	NULL
transcripts	NULL
semiquantitatively	NULL
by	NULL
RT-PCR	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
germline	NULL
transcripts	NULL
was	NULL
confirmed	NULL
by	NULL
obtaining	NULL
PCR	NULL
products	NULL
of	NULL
the	NULL
expected	NULL
molecular	NULL
size	NULL
,	NULL
by	NULL
its	NULL
expression	NULL
pattern	NULL
,	NULL
and	NULL
by	NULL
direct	NULL
partial	NULL
sequencing	NULL
.	NULL

A	NULL
representative	NULL
result	NULL
of	NULL
three	NULL
experiments	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
5	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
GAPDH	NULL
expression	NULL
was	NULL
assessed	NULL
for	NULL
equal	NULL
amounts	NULL
of	NULL
cDNA	NULL
.	NULL

Levels	NULL
of	NULL
epsilon	NULL
germline	NULL
transcription	NULL
were	NULL
increased	NULL
after	NULL
stimulation	NULL
with	NULL
anti-CD40	NULL
+	NULL
IL4	NULL
for	NULL
4	NULL
days	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
RA	NULL
derivates	NULL
(	NULL
all-trans	NULL
and	NULL
13-cis	NULL
RA	NULL
)	NULL
,	NULL
a	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
epsilon	NULL
germline	NULL
transcription	NULL
was	NULL
observed	NULL
(	NULL
shown	NULL
for	NULL
all-frans-RA	NULL
in	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
inhibition	NULL
of	NULL
IgE	NULL
levels	NULL
at	NULL
RA	NULL
concentrations	NULL
tested	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
,	NULL
there	NULL
was	NULL
a	NULL
marked	NULL
inhibition	NULL
of	NULL
epsilon	NULL
germline	NULL
transcription	NULL
at	NULL
10-	NULL
!	NULL

°	NULL
mol/L	NULL
of	NULL
all-trans	NULL
RA	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
semiquantitative	NULL
evaluation	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
RA	NULL
inhibits	NULL
IgE	NULL
production	NULL
affecting	NULL
epsilon	NULL
germline	NULL
transcription	NULL
in	NULL
CD40	NULL
+	NULL
IL-4-stimulated	NULL
B	NULL
cells	NULL
.	NULL

Inhibition	NULL
of	NULL
IgE	NULL
production	NULL
is	NULL
IFN-y	NULL
independent	NULL
.	NULL

To	NULL
explore	NULL
possible	NULL
mechanisms	NULL
involved	NULL
in	NULL
RA-induced	NULL
inhibition	NULL
of	NULL
epsilon	NULL
germline	NULL
transcription	NULL
and	NULL
because	NULL
IFN-y	NULL
is	NULL
known	NULL
to	NULL
inhibit	NULL
IgE	NULL
production	NULL
,	NULL
'*	NULL
we	NULL
examined	NULL
next	NULL
whether	NULL
the	NULL
production	NULL
of	NULL
this	NULL
cytokine	NULL
is	NULL
increased	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RA	NULL
.	NULL

PBMC	NULL
and	NULL
B	NULL
cells	NULL
from	NULL
normal	NULL
donors	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD40	NULL
+	NULL
IL-4	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
2	NULL
,	NULL
baseline	NULL
IFN-y	NULL
production	NULL
of	NULL
unstimulated	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1718	NULL
WORM	NULL
ET	NULL
AL	NULL
B	NULL
8	NULL
FI	NULL
E	NULL
7	NULL
-A-	NULL
IgE	NULL
T	NULL
2	NULL
08	NULL
-o-	NULL
IgM	NULL
§	NULL
8	NULL
.	NULL

-	NULL
»	NULL
-	NULL
IgA	NULL
%	NULL
50	NULL
#	NULL
4	NULL
-o-IgG	NULL
Pd	NULL
Fig	NULL
7	NULL
.	NULL

Effect	NULL
of	NULL
different	NULL
RAR-specific	NULL
retinoids	NULL
on	NULL
Ig	NULL
produc-204	NULL
tion	NULL
by	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
2	NULL
.	NULL

Igs	NULL
(	NULL
IgA	NULL
,	NULL
IgG	NULL
,	NULL
0	NULL
--	NULL
-	NULL
r-	NULL
r	NULL
--	NULL
r	NULL
--	NULL
|-	NULL
and	NULL
IgM	NULL
)	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
§	NULL
1	NULL
f	NULL
z	NULL
T	NULL
g	NULL
E	NULL
g	NULL
3	NULL
ja	NULL
g	NULL
5	NULL
E	NULL
3	NULL
ja	NULL
g	NULL
g	NULL
g	NULL
f	NULL
f	NULL
z	NULL
g	NULL
E	NULL
g	NULL
supernatants	NULL
by	NULL
ELISA	NULL
using	NULL
the	NULL
E	NULL
é	NULL
€	NULL
08	NULL
f	NULL
=	NULL
f	NULL
halle	NULL
=o	NULL
f	NULL
r	NULL
appropriate	NULL
MoAb	NULL
.	NULL

Values	NULL
are	NULL
e	NULL
CD	NULL
336	NULL
cp	NULL
2019	NULL
CD	NULL
437	NULL
cp	NULL
se7	NULL
shown	NULL
as	NULL
means	NULL
percent	NULL
of	NULL
5	NULL
CD40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
.	NULL

cells	NULL
is	NULL
low	NULL
and	NULL
highly	NULL
variable	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
RA	NULL
,	NULL
the	NULL
DISCUSSION	NULL
amounts	NULL
of	NULL
IFN-y	NULL
were	NULL
rather	NULL
decreased	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
CD40	NULL
+	NULL
IL-4-stimulated	NULL
PBMC	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
neither	NULL
all-trans	NULL
nor	NULL
13-cis	NULL
RA	NULL
significantly	NULL
enhanced	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
,	NULL
indicating	NULL
that	NULL
inhibition	NULL
of	NULL
IgE	NULL
synthesis	NULL
by	NULL
both	NULL
RA	NULL
derivatives	NULL
involves	NULL
mechanisms	NULL
other	NULL
than	NULL
IFN-y	NULL
.	NULL

Expression	NULL
of	NULL
retinoic	NULL
acid	NULL
receptors	NULL
on	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
biological	NULL
effects	NULL
of	NULL
RA	NULL
are	NULL
exerted	NULL
through	NULL
binding	NULL
the	NULL
RARa	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
different	NULL
RAR	NULL
in	NULL
unstimulated	NULL
peripheral	NULL
B	NULL
cells	NULL
,	NULL
semiquantitative	NULL
PCR	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
RARa	NULL
«	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
specific	NULL
primers	NULL
.	NULL

Transcripts	NULL
for	NULL
the	NULL
RARa	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
,	NULL
were	NULL
detectable	NULL
in	NULL
unstimulated	NULL
peripheral	NULL
human	NULL
B	NULL
cells	NULL
by	NULL
RT-PCR	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
primers	NULL
for	NULL
RARa	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
were	NULL
used	NULL
in	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
(	NULL
THP-1	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
express	NULL
all	NULL
three	NULL
RAR	NULL
(	NULL
M.	NULL
Babina	NULL
,	NULL
personal	NULL
communication	NULL
,	NULL
November	NULL
1997	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
receptor-specific	NULL
retinoids	NULL
on	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
IgE	NULL
.	NULL

production	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
different	NULL
RAR	NULL
during	NULL
IgE	NULL
production	NULL
was	NULL
determined	NULL
next	NULL
by	NULL
using	NULL
derivates	NULL
of	NULL
RA	NULL
with	NULL
different	NULL
affinity	NULL
toward	NULL
the	NULL
RARa	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
.	NULL

The	NULL
molecular	NULL
weights	NULL
,	NULL
their	NULL
receptor	NULL
specificity	NULL
and	NULL
their	NULL
transcriptional	NULL
activation	NULL
values	NULL
after	NULL
binding	NULL
the	NULL
particular	NULL
receptor	NULL
indicating	NULL
the	NULL
intracellular	NULL
activity	NULL
of	NULL
the	NULL
four	NULL
retinoids	NULL
studied	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
3	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
4	NULL
,	NULL
all	NULL
compounds	NULL
were	NULL
inhibitory	NULL
,	NULL
but	NULL
those	NULL
binding	NULL
RARa	NULL
«	NULL
with	NULL
high-affinity	NULL
did	NULL
so	NULL
by	NULL
greater	NULL
than	NULL
80	NULL
%	NULL
at	NULL
concentrations	NULL
of	NULL
>	NULL
10~	NULL
``	NULL
'	NULL
mol/L	NULL
.	NULL

These	NULL
findings	NULL
were	NULL
further	NULL
confirmed	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
e	NULL
germline	NULL
transcription	NULL
of	NULL
CD40	NULL
+	NULL
IL-4-stimulated	NULL
cells	NULL
was	NULL
only	NULL
inhibited	NULL
at	NULL
concentrations	NULL
above	NULL
10~	NULL
'	NULL
mol/L	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CD336	NULL
and	NULL
CD367	NULL
,	NULL
derivates	NULL
of	NULL
RA	NULL
with	NULL
high	NULL
affinity	NULL
toward	NULL
the	NULL
RARa	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
IgA	NULL
,	NULL
IgG	NULL
,	NULL
and	NULL
IgM	NULL
production	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
RAR-specific	NULL
compounds	NULL
showed	NULL
that	NULL
the	NULL
production	NULL
of	NULL
these	NULL
Igs	NULL
was	NULL
not	NULL
altered	NULL
(	NULL
Table	NULL
1	NULL
,	NULL
Fig	NULL
7	NULL
)	NULL
,	NULL
confirming	NULL
the	NULL
specificity	NULL
by	NULL
which	NULL
RA	NULL
inhibits	NULL
€D40	NULL
+	NULL
IL-4-mediated	NULL
IgE	NULL
production	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
all-trans	NULL
and	NULL
13-cis	NULL
RA	NULL
affects	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
B-cell	NULL
activation	NULL
by	NULL
inhibition	NULL
of	NULL
B-cell	NULL
proliferation	NULL
and	NULL
IgE	NULL
synthesis	NULL
.	NULL

Using	NULL
RAR-specific	NULL
RA	NULL
derivates	NULL
,	NULL
we	NULL
elucidated	NULL
that	NULL
these	NULL
effects	NULL
are	NULL
primarily	NULL
mediated	NULL
via	NULL
the	NULL
nuclear	NULL
RARa	NULL
«	NULL
.	NULL

Because	NULL
the	NULL
physi-ologic	NULL
level	NULL
of	NULL
all-trans	NULL
RA	NULL
in	NULL
serum	NULL
is	NULL
about	NULL
10	NULL
nmol/L	NULL
``	NULL
and	NULL
because	NULL
the	NULL
inhibition	NULL
of	NULL
DNA	NULL
synthesis	NULL
elicited	NULL
by	NULL
all-trans-RA	NULL
at	NULL
this	NULL
concentration	NULL
was	NULL
50	NULL
%	NULL
in	NULL
PBMC	NULL
and	NULL
58	NULL
%	NULL
in	NULL
B	NULL
cells	NULL
after	NULL
CD40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
and	NULL
because	NULL
IgE	NULL
synthesis	NULL
was	NULL
even	NULL
affected	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10-'*	NULL
mol/L	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
10-'°	NULL
mol/L	NULL
in	NULL
PBMC	NULL
,	NULL
marked	NULL
inhibition	NULL
of	NULL
B-cell	NULL
proliferation	NULL
and	NULL
of	NULL
IgE	NULL
production	NULL
must	NULL
be	NULL
assumed	NULL
to	NULL
be	NULL
achievable	NULL
during	NULL
oral	NULL
treatment	NULL
with	NULL
RA	NULL
.	NULL

!	NULL
``	NULL

Presumably	NULL
due	NULL
to	NULL
the	NULL
importance	NULL
of	NULL
retinoids	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
hematologic	NULL
and	NULL
dermatologic	NULL
disorders	NULL
such	NULL
as	NULL
leukemia	NULL
,	NULL
acne	NULL
,	NULL
or	NULL
psoriasis	NULL
,	NULL
the	NULL
focus	NULL
of	NULL
past	NULL
studies	NULL
has	NULL
been	NULL
on	NULL
the	NULL
role	NULL
of	NULL
retinoids	NULL
in	NULL
the	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cells	NULL
and	NULL
keratinocytes	NULL
.	NULL
``	NULL

However	NULL
,	NULL
vitamin	NULL
A	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
key	NULL
regulator	NULL
for	NULL
cell	NULL
growth	NULL
,	NULL
cytokine	NULL
production	NULL
,	NULL
and	NULL
differentiation	NULL
in	NULL
normal	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
The	NULL
growth	NULL
inhibiting	NULL
effects	NULL
of	NULL
retinoids	NULL
on	NULL
B	NULL
lymphoid	NULL
cells	NULL
have	NULL
been	NULL
noticed	NULL
previously	NULL
using	NULL
cell	NULL
lines	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
maturation	NULL
.	NULL
``	NULL

Despite	NULL
the	NULL
dramatic	NULL
effects	NULL
of	NULL
vitamin	NULL
A	NULL
deficiency	NULL
on	NULL
the	NULL
immune	NULL
system	NULL
in	NULL
vivo	NULL
,	NULL
``	NULL
and	NULL
the	NULL
role	NULL
of	NULL
RA	NULL
on	NULL
B-cell	NULL
growth	NULL
and	NULL
differentiation	NULL
in	NULL
vitro	NULL
,	NULL
'	NULL
``	NULL
``	NULL
``	NULL
no	NULL
information	NULL
about	NULL
the	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
isotype	NULL
switching	NULL
and	NULL
Ig	NULL
synthesis	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
is	NULL
available	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
in	NULL
vivo	NULL
experiments	NULL
dealing	NULL
with	NULL
vitamin	NULL
A	NULL
and	NULL
the	NULL
immune	NULL
system	NULL
have	NULL
concluded	NULL
that	NULL
vitamin	NULL
A	NULL
has	NULL
a	NULL
stimulatory	NULL
role	NULL
on	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL
``	NULL

''	NULL
This	NULL
assumption	NULL
is	NULL
based	NULL
on	NULL
deficiency	NULL
studies	NULL
in	NULL
animal	NULL
models	NULL
,	NULL
epidemio-logic	NULL
data	NULL
from	NULL
humans	NULL
,	NULL
as	NULL
well	NULL
as	NULL
data	NULL
on	NULL
supplementation	NULL
of	NULL
retinoids	NULL
showing	NULL
reduced	NULL
infections	NULL
in	NULL
humans	NULL
.	NULL

In	NULL
vitro	NULL
experiments	NULL
using	NULL
isolated	NULL
lymphocytes	NULL
have	NULL
shown	NULL
divergent	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RETINOIC	NULL
ACID	NULL
AND	NULL
B	NULL
CELLS	NULL
effects	NULL
.	NULL

Both	NULL
stimulatory	NULL
and	NULL
inhibitory	NULL
effects	NULL
of	NULL
retinoids	NULL
on	NULL
B	NULL
lymphocytes	NULL
have	NULL
been	NULL
observed	NULL
.	NULL
'	NULL

''	NULL
``	NULL
2	NULL
However	NULL
,	NULL
more	NULL
recent	NULL
studies	NULL
have	NULL
clearly	NULL
shown	NULL
that	NULL
RA	NULL
inhibits	NULL
mitogenic	NULL
activation	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
B	NULL
cells	NULL
,	NULL
``	NULL
in	NULL
line	NULL
with	NULL
the	NULL
present	NULL
results	NULL
.	NULL

Induction	NULL
of	NULL
IgE	NULL
synthesis	NULL
requires	NULL
two	NULL
signals	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
the	NULL
cytokine	NULL
IL-4	NULL
and	NULL
engagement	NULL
of	NULL
the	NULL
B-cell	NULL
antigen	NULL
CD40	NULL
.	NULL

No	NULL
data	NULL
about	NULL
the	NULL
role	NULL
of	NULL
RA	NULL
in	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
IgE	NULL
production	NULL
are	NULL
available	NULL
to	NULL
date	NULL
.	NULL

However	NULL
,	NULL
in	NULL
a	NULL
previous	NULL
study	NULL
using	NULL
an	NULL
in	NULL
vivo	NULL
mouse	NULL
model	NULL
,	NULL
an	NULL
increased	NULL
IgE	NULL
response	NULL
after	NULL
ovalbumin	NULL
(	NULL
OvA	NULL
)	NULL
sensitization	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
RA-pretreated	NULL
mice	NULL
.	NULL
``	NULL

''	NULL
In	NULL
contrast	NULL
to	NULL
these	NULL
findings	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
CD40	NULL
+	NULL
IL-4-mediated	NULL
IgE	NULL
production	NULL
is	NULL
strongly	NULL
inhibited	NULL
by	NULL
RA	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Inhibition	NULL
of	NULL
IgE	NULL
synthesis	NULL
occurs	NULL
at	NULL
very	NULL
low	NULL
concentrations	NULL
(	NULL
down	NULL
to	NULL
10-	NULL
'	NULL
mol/L	NULL
)	NULL
,	NULL
which	NULL
are	NULL
easily	NULL
achieved	NULL
in	NULL
the	NULL
serum	NULL
during	NULL
retinoid	NULL
treatment	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
while	NULL
,	NULL
in	NULL
cultures	NULL
of	NULL
purified	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
concentration	NULL
of	NULL
RA	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
IgE	NULL
synthesis	NULL
is	NULL
substantially	NULL
lower	NULL
than	NULL
for	NULL
proliferation	NULL
is	NULL
not	NULL
the	NULL
case	NULL
in	NULL
PBMC	NULL
,	NULL
suggests	NULL
that	NULL
additional	NULL
factors	NULL
,	NULL
eg	NULL
,	NULL
cytokines	NULL
other	NULL
than	NULL
IFN-y	NULL
,	NULL
may	NULL
prevent	NULL
the	NULL
RA	NULL
susceptibility	NULL
of	NULL
IgE	NULL
synthesis	NULL
.	NULL

Inhibition	NULL
of	NULL
in	NULL
vitro	NULL
IgE	NULL
production	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
with	NULL
all-trans	NULL
RA	NULL
by	NULL
Tokuyama	NULL
et	NULL
al	NULL
``	NULL
in	NULL
the	NULL
murine	NULL
system	NULL
.	NULL

These	NULL
investigators	NULL
used	NULL
IL-4	NULL
+	NULL
hydrocortisone-stimulated	NULL
splenic	NULL
B	NULL
cells	NULL
from	NULL
mice	NULL
and	NULL
detected	NULL
a	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RA	NULL
.	NULL

We	NULL
show	NULL
here	NULL
for	NULL
the	NULL
first	NULL
time	NULL
an	NULL
inhibition	NULL
of	NULL
CD40	NULL
+	NULL
IL-4-induced	NULL
IgE	NULL
production	NULL
in	NULL
human	NULL
peripheral	NULL
B	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
demonstrate	NULL
inhibition	NULL
of	NULL
epsilon	NULL
germline	NULL
transcription	NULL
by	NULL
RA	NULL
suggesting	NULL
thus	NULL
a	NULL
molecular	NULL
mechanism	NULL
of	NULL
RA	NULL
dependent	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
.	NULL

Epsilon	NULL
germline	NULL
transcription	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
IgE	NULL
isotype	NULL
switching	NULL
,	NULL
because	NULL
deletion	NULL
of	NULL
the	NULL
I	NULL
exon	NULL
in	NULL
mice	NULL
results	NULL
in	NULL
significant	NULL
impairment	NULL
of	NULL
IgE	NULL
production	NULL
.	NULL
``	NULL

''	NULL
Therefore	NULL
,	NULL
inhibition	NULL
of	NULL
epsilon	NULL
germline	NULL
transcription	NULL
by	NULL
RA	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IgE	NULL
production	NULL
after	NULL
€D40	NULL
+	NULL
IL-4	NULL
stimulation	NULL
in	NULL
vivo	NULL
.	NULL

That	NULL
RA	NULL
is	NULL
capable	NULL
of	NULL
affecting	NULL
Ig	NULL
production	NULL
in	NULL
mice	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
other	NULL
studies	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
B	NULL
cells	NULL
seems	NULL
to	NULL
depend	NULL
on	NULL
the	NULL
model	NULL
or	NULL
the	NULL
type	NULL
of	NULL
stimulation	NULL
used	NULL
since	NULL
in	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-stimulated	NULL
splenic	NULL
B	NULL
cells	NULL
,	NULL
enhancement	NULL
of	NULL
germline	NULL
C	NULL
a	NULL
transcripts	NULL
was	NULL
determined	NULL
,	NULL
while	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
IL-4-induced	NULL
I	NULL
y	NULL
expression	NULL
was	NULL
completely	NULL
abolished	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RA	NULL
.	NULL
``	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
currently	NULL
available	NULL
data	NULL
strongly	NULL
support	NULL
the	NULL
concept	NULL
that	NULL
RA	NULL
is	NULL
capable	NULL
of	NULL
modulating	NULL
Ig	NULL
production	NULL
significantly	NULL
even	NULL
at	NULL
the	NULL
level	NULL
of	NULL
isotype	NULL
switching	NULL
.	NULL

However	NULL
,	NULL
this	NULL
does	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
other	NULL
mechanisms	NULL
are	NULL
operative	NULL
in	NULL
addition	NULL
,	NULL
possibly	NULL
via	NULL
the	NULL
action	NULL
of	NULL
cytokines	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
cytokines	NULL
including	NULL
tumor	NULL
necrosis	NULL
factor-e	NULL
(	NULL
TNF-a	NULL
)	NULL
,	NULL
IL-5	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
IL-10	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
transforming	NULL
growth	NULL
factor-	NULL
(	NULL
TGE-B	NULL
)	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
modulate	NULL
IgE	NULL
production	NULL
.	NULL
``	NULL

''	NULL
Because	NULL
IFN-y	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
IgE	NULL
production	NULL
,	NULL
``	NULL
``	NULL
we	NULL
studied	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RA	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
any	NULL
enhancing	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
suggests	NULL
that	NULL
inhibition	NULL
of	NULL
IgE	NULL
production	NULL
is	NULL
IFN-y	NULL
independent	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
IgE	NULL
synthesis	NULL
in	NULL
B	NULL
cells	NULL
was	NULL
more	NULL
inhibited	NULL
than	NULL
in	NULL
PBMC	NULL
where	NULL
IFN-y	NULL
production	NULL
is	NULL
produced	NULL
by	NULL
monocytes	NULL
or	NULL
TH1	NULL
cells	NULL
also	NULL
speaks	NULL
against	NULL
1719	NULL
a	NULL
role	NULL
of	NULL
IFN-y	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
data	NULL
observed	NULL
with	NULL
RA	NULL
.	NULL

Another	NULL
cytokine	NULL
that	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
IgE-production	NULL
by	NULL
RA	NULL
is	NULL
TGF-B	NULL
.	NULL

This	NULL
cytokine	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
RA	NULL
in	NULL
keratinocytes	NULL
.	NULL
``	NULL

TGF-B	NULL
is	NULL
a	NULL
potent	NULL
immunosuppressive	NULL
cytokine	NULL
and	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
IgE	NULL
and	NULL
epsilon	NULL
germline	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL
``	NULL

''	NULL
Whether	NULL
TGF-B	NULL
production	NULL
is	NULL
increased	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RA	NULL
in	NULL
PBMC	NULL
or	NULL
B	NULL
cells	NULL
is	NULL
currently	NULL
under	NULL
investigation	NULL
.	NULL

However	NULL
,	NULL
a	NULL
study	NULL
by	NULL
Tokuyama	NULL
et	NULL
al	NULL
``	NULL
has	NULL
shown	NULL
a	NULL
TGF-f	NULL
independent	NULL
modulation	NULL
of	NULL
germline	NULL
transcription	NULL
in	NULL
LPS/IL-4-stimulated	NULL
mouse	NULL
B	NULL
cells	NULL
.	NULL

At	NULL
the	NULL
molecular	NULL
level	NULL
,	NULL
retinoids	NULL
bind	NULL
to	NULL
and	NULL
activate	NULL
specific	NULL
nuclear	NULL
receptors	NULL
,	NULL
the	NULL
RARs	NULL
and	NULL
retinoic	NULL
X	NULL
receptors	NULL
(	NULL
RXRs	NULL
)	NULL
.	NULL

These	NULL
recognize	NULL
specific	NULL
DNA	NULL
sequences	NULL
as	NULL
homo-	NULL
or	NULL
heterodimers	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
,	NULL
bind	NULL
specific	NULL
DNA	NULL
sequences	NULL
regulating	NULL
gene	NULL
expression	NULL
.	NULL
``	NULL

Whether	NULL
RA	NULL
binding	NULL
proteins	NULL
can	NULL
directly	NULL
interact	NULL
with	NULL
the	NULL
epsilon	NULL
germline	NULL
promoter	NULL
region	NULL
is	NULL
an	NULL
interesting	NULL
possibility	NULL
that	NULL
will	NULL
have	NULL
to	NULL
be	NULL
explored	NULL
in	NULL
future	NULL
studies	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
R.	NULL
Geha	NULL
(	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
purified	NULL
anti-CD40	NULL
MoAb	NULL
and	NULL
Dr	NULL
R.	NULL
Hamiliton	NULL
(	NULL
Asthma	NULL
and	NULL
Allergy	NULL
Center	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
anti-IgE	NULL
MoAb	NULL
,	NULL
Dr	NULL
M.	NULL
Babina	NULL
for	NULL
help	NULL
with	NULL
the	NULL
RAR	NULL
PCR	NULL
,	NULL
and	NULL
K.	NULL
Ebermayer	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Prof	NULL
A.	NULL
Radbruch	NULL
(	NULL
Deutsches	NULL
Rheuma-Forschungszentrum	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
cooperation	NULL
and	NULL
support	NULL
in	NULL
Ig	NULL
M-	NULL
B	NULL
cell	NULL
purification	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Goodman	NULL
DS	NULL
:	NULL
Vitamin	NULL
A	NULL
and	NULL
retinoids	NULL
in	NULL
health	NULL
and	NULL
disease	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
310:1023	NULL
,	NULL
1984	NULL
2	NULL
.	NULL

Fahlman	NULL
C	NULL
,	NULL
Jacobsen	NULL
SE	NULL
,	NULL
Smeland	NULL
EB	NULL
,	NULL
Lomo	NULL
J	NULL
,	NULL
Naess	NULL
CE	NULL
,	NULL
Funderud	NULL
S	NULL
,	NULL
Blomhoff	NULL
HK	NULL
:	NULL
All-trans	NULL
and	NULL
9-cis-	NULL
retinoic	NULL
acid	NULL
inhibit	NULL
growth	NULL
of	NULL
normal	NULL
human	NULL
and	NULL
murine	NULL
B	NULL
cell	NULL
precursors	NULL
.	NULL

J	NULL
Immunol	NULL
155:58	NULL
,	NULL
1995	NULL
3	NULL
.	NULL

Armitage	NULL
RJ	NULL
,	NULL
Macduff	NULL
BM	NULL
,	NULL
Spriggs	NULL
MK	NULL
,	NULL
Fanslow	NULL
WC	NULL
:	NULL
Human	NULL
B	NULL
cell	NULL
proliferation	NULL
and	NULL
Ig	NULL
secretion	NULL
induced	NULL
by	NULL
recombinant	NULL
CD40	NULL
ligand	NULL
are	NULL
modulated	NULL
by	NULL
soluble	NULL
cytokines	NULL
.	NULL

J	NULL
Immunol	NULL
150:3671	NULL
,	NULL
1993	NULL
4	NULL
.	NULL

Jabara	NULL
HH	NULL
,	NULL
Fu	NULL
SM	NULL
,	NULL
Geha	NULL
RS	NULL
,	NULL
Vercelli	NULL
D	NULL
:	NULL
CD	NULL
40	NULL
and	NULL
IgE	NULL
:	NULL
Synergism	NULL
between	NULL
anti-CD40	NULL
monoclonal	NULL
antibody	NULL
and	NULL
interleukin	NULL
4	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IgE	NULL
synthesis	NULL
by	NULL
highly	NULL
purified	NULL
B-cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:1861	NULL
,	NULL
1990	NULL
5	NULL
.	NULL

Gauchat	NULL
JF	NULL
,	NULL
Lebman	NULL
D	NULL
,	NULL
Coffman	NULL
R	NULL
,	NULL
Gascan	NULL
H	NULL
,	NULL
deVries	NULL
JE	NULL
:	NULL
Structure	NULL
and	NULL
expression	NULL
of	NULL
germline	NULL
e	NULL
transcripts	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
induced	NULL
by	NULL
interleukin	NULL
4	NULL
to	NULL
switch	NULL
to	NULL
IgE	NULL
production	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:463	NULL
,	NULL
1990	NULL
6	NULL
.	NULL

Ramesh	NULL
N	NULL
,	NULL
Morio	NULL
T	NULL
,	NULL
Fuleihan	NULL
R	NULL
,	NULL
Worm	NULL
M	NULL
,	NULL
Horner	NULL
A	NULL
,	NULL
Tsitsikovy	NULL
E	NULL
,	NULL
Castigli	NULL
E	NULL
,	NULL
Geha	NULL
RS	NULL
:	NULL
CD40-CD40	NULL
ligand	NULL
(	NULL
CD4O0L	NULL
)	NULL
interactions	NULL
and	NULL
X-linked	NULL
hyper-IgM	NULL
syndrome	NULL
(	NULL
HIGMX-1	NULL
)	NULL
.	NULL

Clin	NULL
Immunol	NULL
Immuno-pathol	NULL
76:5208	NULL
,	NULL
1995	NULL
7	NULL
.	NULL

Kimata	NULL
H	NULL
,	NULL
Yoshida	NULL
A	NULL
,	NULL
Ishioka	NULL
C	NULL
,	NULL
Lindley	NULL
I	NULL
,	NULL
Mikawa	NULL
H	NULL
:	NULL
Interleu-kin-8	NULL
(	NULL
IL-8	NULL
)	NULL
selectively	NULL
inhibits	NULL
immunoglobulin	NULL
E	NULL
production	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
176:1227	NULL
,	NULL
1992	NULL
8	NULL
.	NULL

Kiniwa	NULL
M	NULL
,	NULL
Gately	NULL
M	NULL
,	NULL
Gubler	NULL
U	NULL
,	NULL
Chizzonite	NULL
R	NULL
,	NULL
Fargeas	NULL
C	NULL
,	NULL
Delespesse	NULL
G	NULL
:	NULL
Recombinant	NULL
interleukin-12	NULL
suppresses	NULL
the	NULL
of	NULL
immunoglobulin	NULL
E	NULL
by	NULL
interleukin-4	NULL
stimulated	NULL
human	NULL
lymphocytes	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
90:262	NULL
,	NULL
1992	NULL
9	NULL
.	NULL

Vercelli	NULL
D	NULL
,	NULL
Jabara	NULL
H	NULL
,	NULL
Arai	NULL
K	NULL
:	NULL
Endogenous	NULL
IL-6	NULL
plays	NULL
an	NULL
obligatory	NULL
role	NULL
in	NULL
IL-4	NULL
induced	NULL
human	NULL
IgE	NULL
synthesis	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
19:1419	NULL
,	NULL
1989	NULL
10	NULL
.	NULL

Funderud	NULL
S	NULL
,	NULL
Erikstein	NULL
B	NULL
,	NULL
Asheim	NULL
HC	NULL
,	NULL
Nustad	NULL
K	NULL
,	NULL
Stokke	NULL
T	NULL
,	NULL
Blomhoff	NULL
HK	NULL
,	NULL
Holte	NULL
H	NULL
,	NULL
Smeland	NULL
EB	NULL
:	NULL
Functional	NULL
properties	NULL
of	NULL
CD19	NULL
+	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1720	NULL
B	NULL
lymphocytes	NULL
positively	NULL
selected	NULL
from	NULL
buffy	NULL
coats	NULL
by	NULL
immunomag-netic	NULL
separation	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
20:201	NULL
,	NULL
1990	NULL
11	NULL
.	NULL

Rosewics	NULL
S	NULL
,	NULL
Stier	NULL
U	NULL
,	NULL
Brembek	NULL
F	NULL
,	NULL
Kaiser	NULL
A	NULL
,	NULL
Papadimitriou	NULL
CA	NULL
,	NULL
Berdel	NULL
WE	NULL
,	NULL
Wiedenmann	NULL
B	NULL
,	NULL
Rieken	NULL
EO	NULL
:	NULL
Retinoids	NULL
:	NULL
Effects	NULL
on	NULL
growth	NULL
,	NULL
and	NULL
nuclear	NULL
receptor	NULL
expression	NULL
in	NULL
human	NULL
pancreatic	NULL
carcinoma	NULL
cell	NULL
lines	NULL
.	NULL

Gastroenterology	NULL
109:1646	NULL
,	NULL
1995	NULL
12	NULL
.	NULL

Thienes	NULL
CP	NULL
,	NULL
De-Monte	NULL
L	NULL
,	NULL
Monticelli	NULL
S	NULL
,	NULL
Busslinger	NULL
M	NULL
,	NULL
Gould	NULL
HJ	NULL
,	NULL
Vercelli	NULL
D	NULL
:	NULL
The	NULL
transcription	NULL
factor	NULL
B	NULL
cell-specific	NULL
activator	NULL
protein	NULL
(	NULL
BSAP	NULL
)	NULL
enhances	NULL
both	NULL
IL-4	NULL
and	NULL
CD40	NULL
mediated	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
epsilon	NULL
germline	NULL
promotor	NULL
.	NULL

J	NULL
Immunol	NULL
158:5874	NULL
,	NULL
1997	NULL
13	NULL
.	NULL

Vercelli	NULL
D	NULL
,	NULL
Geha	NULL
RS	NULL
:	NULL
Regulation	NULL
of	NULL
isotype	NULL
switching	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
4:794	NULL
,	NULL
1992	NULL
14	NULL
.	NULL

Pene	NULL
J	NULL
,	NULL
Rousset	NULL
F	NULL
,	NULL
Briere	NULL
F	NULL
,	NULL
Chretien	NULL
I	NULL
,	NULL
Bonnefoy	NULL
J-Y	NULL
,	NULL
Spits	NULL
H	NULL
,	NULL
Yokota	NULL
T	NULL
,	NULL
Arai	NULL
N	NULL
,	NULL
Arai	NULL
K-I	NULL
,	NULL
Banchereau	NULL
J	NULL
,	NULL
deVries	NULL
JE	NULL
:	NULL
IgE	NULL
production	NULL
by	NULL
normal	NULL
human	NULL
lymphocytes	NULL
is	NULL
induced	NULL
by	NULL
interleukin	NULL
4	NULL
and	NULL
suppressed	NULL
by	NULL
interferons	NULL
y	NULL
and	NULL
a	NULL
and	NULL
prostaglandin	NULL
EZ	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:6880	NULL
,	NULL
1988	NULL
15	NULL
.	NULL

De	NULL
Ruyter	NULL
M	NULL
,	NULL
Lambert	NULL
WE	NULL
,	NULL
DeLeenheer	NULL
AP	NULL
:	NULL
Retinoic	NULL
acid	NULL
:	NULL
As	NULL
endogenous	NULL
compound	NULL
of	NULL
human	NULL
blood	NULL
.	NULL

Unequivocal	NULL
demonstration	NULL
of	NULL
endogenous	NULL
retinoic	NULL
acid	NULL
in	NULL
normal	NULL
physiological	NULL
conditions	NULL
.	NULL

Anal	NULL
Biochem	NULL
98:402	NULL
,	NULL
1979	NULL
16	NULL
.	NULL

Maier	NULL
H	NULL
,	NULL
Honigsmann	NULL
H	NULL
;	NULL
Concentration	NULL
of	NULL
etrenitate	NULL
in	NULL
plasma	NULL
and	NULL
subcutaneous	NULL
fat	NULL
after	NULL
long	NULL
term	NULL
acitretin	NULL
.	NULL

Lancet	NULL
348:1107	NULL
,	NULL
1996	NULL
17	NULL
.	NULL

Jacobsen	NULL
SEW	NULL
,	NULL
Fahlman	NULL
C	NULL
,	NULL
Blomhoff	NULL
HK	NULL
,	NULL
Okkenhaug	NULL
C	NULL
,	NULL
Rusten	NULL
LS	NULL
,	NULL
Smeland	NULL
EB	NULL
:	NULL
All-trans	NULL
and	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
:	NULL
Potent	NULL
direct	NULL
inhibitors	NULL
of	NULL
primitive	NULL
murine	NULL
hematopoetic	NULL
progenitors	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
179:1665	NULL
,	NULL
1994	NULL
18	NULL
.	NULL

Smeland	NULL
EB	NULL
,	NULL
Rusten	NULL
L	NULL
,	NULL
Jacobsen	NULL
SEW	NULL
,	NULL
Skrede	NULL
B	NULL
,	NULL
Blomhoff	NULL
R	NULL
,	NULL
Wang	NULL
MY	NULL
,	NULL
Funderud	NULL
S	NULL
,	NULL
Kvalheim	NULL
G	NULL
,	NULL
Blomhoff	NULL
HK	NULL
:	NULL
All-trans	NULL
retinoic	NULL
acid	NULL
directly	NULL
inhibits	NULL
G-CSF	NULL
induced	NULL
proliferation	NULL
of	NULL
CD34+	NULL
human	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
.	NULL

Blood	NULL
84:2490	NULL
,	NULL
1994	NULL
19	NULL
.	NULL

Blomhoff	NULL
HK	NULL
,	NULL
Smeland	NULL
EB	NULL
,	NULL
Erikstein	NULL
B	NULL
,	NULL
Rasmussen	NULL
AM	NULL
,	NULL
Skrede	NULL
B	NULL
,	NULL
Skjonsberg	NULL
C	NULL
,	NULL
Blomhoff	NULL
R	NULL
:	NULL
Vitamin	NULL
A	NULL
is	NULL
a	NULL
key	NULL
regulator	NULL
for	NULL
cell	NULL
growth	NULL
,	NULL
cytokine	NULL
production	NULL
and	NULL
differentiation	NULL
in	NULL
normal	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:23988	NULL
,	NULL
1992	NULL
20	NULL
.	NULL

Buck	NULL
J	NULL
,	NULL
Ritter	NULL
G	NULL
,	NULL
Dannecker	NULL
L	NULL
,	NULL
Katta	NULL
V	NULL
,	NULL
Cohen	NULL
SL	NULL
,	NULL
Chait	NULL
BT	NULL
,	NULL
Himmerling	NULL
U	NULL
:	NULL
Retinol	NULL
is	NULL
essential	NULL
for	NULL
growth	NULL
of	NULL
activated	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
171:1613	NULL
,	NULL
1990	NULL
21	NULL
.	NULL

Blomhoff	NULL
HK	NULL
,	NULL
Smeland	NULL
EB	NULL
:	NULL
Role	NULL
of	NULL
retinoids	NULL
in	NULL
normal	NULL
hemato-poiesis	NULL
and	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Vitamin	NULL
A	NULL
in	NULL
health	NULL
and	NULL
disease	NULL
1:451	NULL
,	NULL
1994	NULL
WORM	NULL
ET	NULL
AL	NULL
22	NULL
.	NULL

Bosma	NULL
M	NULL
,	NULL
Sidell	NULL
N	NULL
:	NULL
Retinoic	NULL
acid	NULL
inhibits	NULL
CaZ2+	NULL
currents	NULL
and	NULL
cell	NULL
proliferation	NULL
in	NULL
a	NULL
B	NULL
lymphocyte	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
135:317	NULL
,	NULL
1988	NULL
23	NULL
.	NULL

Barnett	NULL
JB	NULL
:	NULL
Immunopotentation	NULL
of	NULL
the	NULL
IgE	NULL
antibody	NULL
response	NULL
by	NULL
13-cis	NULL
retinoic	NULL
acid	NULL
.	NULL

Int	NULL
Arch	NULL
Allergy	NULL
Immunol	NULL
67:287	NULL
,	NULL
1982	NULL
24	NULL
.	NULL

Tokuyama	NULL
Y	NULL
,	NULL
Tokuyama	NULL
H	NULL
:	NULL
Retinoids	NULL
as	NULL
Ig	NULL
isotype	NULL
switch	NULL
modulators	NULL
.	NULL

The	NULL
role	NULL
of	NULL
retinoids	NULL
in	NULL
directing	NULL
isotype	NULL
switching	NULL
to	NULL
IgA	NULL
and	NULL
IgG1	NULL
(	NULL
IgE	NULL
)	NULL
in	NULL
association	NULL
with	NULL
IL-4	NULL
and	NULL
IL-5	NULL
.	NULL

Cell	NULL
Immunol	NULL
170:230	NULL
,	NULL
1996	NULL
25	NULL
.	NULL

Bottaro	NULL
A	NULL
,	NULL
Lansford	NULL
R	NULL
,	NULL
Xu	NULL
L	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Rothman	NULL
P	NULL
,	NULL
Alt	NULL
FW	NULL
:	NULL
S	NULL
region	NULL
transcription	NULL
per	NULL
se	NULL
promotes	NULL
basal	NULL
IgE	NULL
class	NULL
switching	NULL
recombination	NULL
but	NULL
additional	NULL
factors	NULL
regulate	NULL
the	NULL
efficiancy	NULL
of	NULL
the	NULL
process	NULL
.	NULL

EMBO	NULL
J	NULL
13:665	NULL
,	NULL
1994	NULL
26	NULL
.	NULL

Tokuyama	NULL
H	NULL
,	NULL
Tokuyama	NULL
Y	NULL
,	NULL
Nakanishi	NULL
K	NULL
:	NULL
Retinoids	NULL
inhibit	NULL
IL-4-dependent	NULL
IgE	NULL
and	NULL
IgG1	NULL
production	NULL
by	NULL
LPS-stimulated	NULL
murine	NULL
splenic	NULL
B	NULL
cells	NULL
.	NULL

Cell	NULL
Immunol	NULL
162:153	NULL
,	NULL
1995	NULL
27	NULL
.	NULL

Gauchat	NULL
J-F	NULL
,	NULL
Aversa	NULL
G	NULL
,	NULL
Gascan	NULL
H	NULL
,	NULL
deVries	NULL
JE	NULL
:	NULL
Modulation	NULL
of	NULL
IL-4-induced	NULL
germline	NULL
e	NULL
RNA	NULL
synthesis	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
a	NULL
,	NULL
anti-CD40	NULL
monoclonal	NULL
antibodies	NULL
or	NULL
transforming	NULL
growth	NULL
factor-B	NULL
correlates	NULL
with	NULL
levels	NULL
of	NULL
IgE	NULL
production	NULL
.	NULL

Int	NULL
Immunol	NULL
4:397	NULL
,	NULL
1991	NULL
28	NULL
.	NULL

Xu	NULL
L	NULL
,	NULL
Rothmann	NULL
P	NULL
:	NULL
IFNy	NULL
represses	NULL
e	NULL
germline	NULL
transcription	NULL
and	NULL
subsequently	NULL
downregulates	NULL
switch	NULL
recombination	NULL
to	NULL
e.	NULL
Int	NULL
Immunol	NULL
6:515	NULL
,	NULL
1994	NULL
29	NULL
.	NULL

Glick	NULL
AB	NULL
,	NULL
Flanders	NULL
KC	NULL
,	NULL
Danielpour	NULL
D	NULL
,	NULL
Yuspa	NULL
SH	NULL
,	NULL
Sporn	NULL
MB	NULL
:	NULL
Retinoic	NULL
acid	NULL
induces	NULL
transforming	NULL
growth	NULL
factor	NULL
B2	NULL
in	NULL
cultured	NULL
keratinocytes	NULL
and	NULL
mouse	NULL
epidermis	NULL
.	NULL

Cell	NULL
Reg	NULL
1:87	NULL
,	NULL
1989	NULL
30	NULL
.	NULL

Wu	NULL
CY	NULL
,	NULL
Brinkmann	NULL
V	NULL
,	NULL
Cox	NULL
D	NULL
:	NULL
Modulation	NULL
of	NULL
human	NULL
IgE	NULL
synthesis	NULL
by	NULL
transforming	NULL
growth	NULL
factor	NULL
B.	NULL
Clin	NULL
Immunol	NULL
Immuno-pathol	NULL
62:277	NULL
,	NULL
1992	NULL
31	NULL
.	NULL

Tokuyama	NULL
H	NULL
,	NULL
Tokuyama	NULL
Y	NULL
:	NULL
Retinoic	NULL
acid	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
germ-line	NULL
C	NULL
alpha	NULL
transcript	NULL
mainly	NULL
by	NULL
a	NULL
TGFB	NULL
independent	NULL
mechanism	NULL
.	NULL

Cell	NULL
Immunol	NULL
176:14	NULL
,	NULL
1997	NULL
32	NULL
.	NULL

Kastner	NULL
PM	NULL
,	NULL
Mark	NULL
M	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
Nonsteroid	NULL
nuclear	NULL
recep-tors	NULL
:	NULL
What	NULL
are	NULL
genetic	NULL
studies	NULL
telling	NULL
us	NULL
about	NULL
their	NULL
role	NULL
in	NULL
real	NULL
life	NULL
.	NULL

Cell	NULL
83:859	NULL
,	NULL
1995	NULL
33	NULL
.	NULL

Bernard	NULL
B	NULL
,	NULL
Bernadon	NULL
J	NULL
,	NULL
Delescluse	NULL
C	NULL
,	NULL
Martin	NULL
B	NULL
,	NULL
Lenoir	NULL
M	NULL
,	NULL
Maignan	NULL
J	NULL
,	NULL
Charpentier	NULL
B	NULL
,	NULL
Pilgrim	NULL
W	NULL
,	NULL
Reichert	NULL
U	NULL
,	NULL
Shroot	NULL
B	NULL
:	NULL
Identification	NULL
of	NULL
synthetic	NULL
retinoids	NULL
with	NULL
selectivity	NULL
for	NULL
human	NULL
18	NULL
nuclear	NULL
retinoic	NULL
acid	NULL
receptor	NULL
gamma	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
186:977	NULL
,	NULL
1992	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blOOd	NULL
1998	NULL
92	NULL
:	NULL
1713-1720	NULL
Retinoic	NULL
Acid	NULL
Inhibits	NULL
CD40	NULL
+	NULL
Interleukin-4-Mediated	NULL
IgE	NULL
Production	NULL
In	NULL
Vitro	NULL
M.	NULL
Worm	NULL
,	NULL
J.M	NULL
.	NULL

Krah	NULL
,	NULL
R.A.	NULL
Manz	NULL
and	NULL
B.M	NULL
.	NULL

Henz	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/92/5/1713.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Immunobiology	NULL
and	NULL
Immunotherapy	NULL
(	NULL
5678	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

